Introduction {#s1}
============

Hair cells are mechanoreceptors that convert mechanical stimuli provided by sound and acceleration into electrical signals. In the snail-shaped mammalian cochlea, hair cells are organized into three rows of outer hair cells (OHCs) and one row of inner hair cells (IHCs) that run along the length of the cochlear duct. The cochlea is tonotopically organized, where hair cells at the base of the cochlea signal high-frequency sounds and hair cells at the apex catch low-frequency sounds, with a gradient in between. OHCs amplify input sound signals whereas IHCs transmit sound information to the central nervous system (CNS).

The mechanotransduction complex in cochlear hair cells consists of a multitude of proteins, including ion channel subunits, cell adhesion proteins, myosin motors, and scaffolding proteins that are critical to sense sound-induced force ([@bib41]). The transmembrane proteins TMC1, TMC2, lipoma HMGIC fusion partner-like 5 (LHFPL5), and transmembrane inner ear expressed protein (TMIE), are thought to be integral components of the MET channels in hair cells. TMC1 and TMC2 have been proposed to be the pore-forming subunits of the MET channel in hair cells ([@bib2]; [@bib9]; [@bib23]; [@bib31]). Consistent with this model, MET currents are absent in hair cells from mice lacking both TMC1 and TMC2 ([@bib22]), while the unitary conductance, permeability, and ion selectivity of the MET channel differs between hair cells expressing only TMC1 or TMC2 ([@bib6]; [@bib5]; [@bib13]; [@bib11]; [@bib12]; [@bib24]; [@bib30]). Finally, cysteine mutagenesis experiments are consistent with the model that TMC1 is a pore-forming subunit of the hair-cell MET channel ([@bib31]). However, all efforts have so far failed to express TMC proteins in heterologous cells to reconstitute ion channel function ([@bib9]; [@bib38]). Interestingly, MET responses in OHCs vary tonotopically, and a lack of TMC1 and LHFPL5, but not TMC2, abolishes the tonotopic gradient in the MET response ([@bib5]; [@bib7]). While changes in the levels of expression of TMC1 from the base to the apex have been proposed to underlie the tonotopic gradient in the MET response, the mechanisms that cause the tonotopic gradient are not completely defined ([@bib8]; [@bib4]; [@bib32]; [@bib35]).

TMC orthologues in other species have been linked to a diversity of functions. In *Drosophila melanogaster*, TMC is expressed in the class I and class II dendritic arborization neurons and bipolar dendrite neurons, which are critical for larval locomotion ([@bib18]). TMC is also enriched in md-L neurons that sense food texture ([@bib44]), and for proprioceptor-mediated direction selectivity ([@bib19]). In *Caenorhabditis elegans*, TMC1 regulates development and sexual behavior ([@bib43]), and is required for the alkaline sensitivity of ASH nociceptive neurons ([@bib36]). While efforts have failed to demonstrate that TMCs in flies and worms are mechanically gated ion channels, recent mechanistic studies in worms have shown that TMC1 and TMC2 regulate membrane excitability and egg-laying behavior by conferring a leak conductance ([@bib42]). This raises the question of whether mammalian TMC1 and TMC2 only function as components of mechanically gated ion channels, or possess additional roles critical for mechanosensory hair-cell function.

In this study, we set out to determine the non-MET functions of TMCs and to tackle the link with hair-cell function by manipulating TMCs genetically and monitoring membrane current and potential in mouse hair cells. We sought out potential molecular and cellular mechanisms underlying TMCs and their correlated relevance in auditory transduction.

Results {#s2}
=======

TMC1 but not TMC2 mediates a background current in hair cells {#s2-1}
-------------------------------------------------------------

During the whole-cell voltage-clamp recording from P6 outer hair cells (OHCs) ([Figure 1A](#fig1){ref-type="fig"}) in regular 144 mM Na^+^-containing external solution (144 Na), we always recorded a 'leaky' membrane current (I~m~, 73 pA on average) ([Figure 1B,C](#fig1){ref-type="fig"}). When Na^+^ was replaced in the external solution by N-methyl-D-glucamine (NMDG^+^) (144 NMDG), the I~m~ was small ([Figure 1B](#fig1){ref-type="fig"}), demonstrating that this background current is significantly carried by an ion channel in the cell membrane. When reperfused with 144 Na solution, the current baseline returned to 'leaky' status ([Figure 1B](#fig1){ref-type="fig"}). However, the I~m~ was markedly diminished in *Tmc1*-knockout OHCs ([Figure 1B,C](#fig1){ref-type="fig"}). For more accurate quantification, the amplitude of the background current (I~BG~) was calculated by subtracting the I~m~ in 144 NMDG solution (I~NMDG~) from that in 144 Na solution (I~Na~) ([Figure 1B](#fig1){ref-type="fig"}). On average, the I~NMDG~ (7 pA) in wild-type OHCs was larger than that (4 pA) in *Tmc1*-knockout OHCs, but both were small ([Figure 1D](#fig1){ref-type="fig"}); the I~BG~ in wild-type OHCs was 71 pA, while it was reduced to 18 pA in *Tmc1*-knockout OHCs ([Figure 1E](#fig1){ref-type="fig"}). Furthermore, the voltage dependence of I~m~ and I~NMDG~ was analyzed by applying a series of voltage-pulse stimuli to OHCs ([Figure 1F--I](#fig1){ref-type="fig"}). The I~m~-V curves obtained from these measurements verified a reduced I~m~ ([Figure 1G](#fig1){ref-type="fig"}) and a more negative reversal potential ([Figure 1H](#fig1){ref-type="fig"}) in *Tmc1*-knockout OHCs. After subtraction (only inward I~BG~ was calculated because NMDG was applied extracellularly), it was clear that the I~BG~ altered almost linearly with holding potentials and was dramatically reduced in *Tmc1*-knockout OHCs ([Figure 1I](#fig1){ref-type="fig"}).

![TMC1 mediates a background current in outer hair cells.\
(**A**) Diagram of the recording configuration. The P6 outer hair cells (OHCs, mostly P6 apical-middle OHCs if not specified otherwise) in acutely dissociated cochlea were whole-cell voltage-clamped with Cs^+^ in the recording electrode and perfused with either 144 Na or 144 NMDG external solutions. 144 Na, regular recording solution; 144 NMDG, Na^+^ substituted with NMDG^+^. (**B**) Representative traces of membrane current (I~m~) in OHCs from wild-type and *Tmc1*-knockout (*Tmc1 KO*) mice. The light gray and pink traces were recorded traces that were low-pass filtered to less noisy traces shown in black and red (similar filtering applied in the following figures). I~BG~ (background current) was calculated by subtraction of I~m~ in 144 Na (I~Na~) and I~m~ in 144 NMDG (I~NMDG~) to exclude technical leak. (**C--E**) Quantification of the I~Na~ (**C**), I~NMDG~ (**D**), and I~BG~ (**E**) measured from recordings similar to (**B**). Wild-type I~Na~, --73 ± 6 pA, *Tmc1*-knockout I~Na~, --21 ± 3 pA; wild-type I~NMDG~, --7 ± 1 pA, *Tmc1*-knockout I~NMDG~, --4 ± 1 pA; wild-type I~BG~, --71 ± 5 pA, *Tmc1*-knockout I~BG~, --18 ± 2 pA (**F**). Example of I~m~ in wild-type (black and gray) and *Tmc1*-knockout (red and pink) OHCs undergoing a series of membrane depolarization, with tissues bathed in 144 Na followed by 144 NMDG. (**G--I**) Composite data showing I-V curve (**G**), reversal potential (**H**), and I~BG~ (**I**) measured and calculated from recordings similar to (**F**). (**G**) I-V curve from recordings in 144 Na. (**H**) Mean reversal potentials calculated from I-V curve recorded in OHCs in 144 Na. (**I**) I~BG~-V curve after subtracting I~NMDG~. Only inward current was measured because NMDG was only applied extracellularly. The external solution contained 1.3 mM Ca^2+^. The holding potential was −70 mV. Data are presented as mean ± SEM. N values are shown in each panel. \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001, Student's t-test.\
10.7554/eLife.47441.003Figure 1---source data 1.TMC1 mediates a background current in outer hair cells.](elife-47441-fig1){#fig1}

We next considered whether overexpression of TMC1 would enhance the background current in hair cells. Three constructs were used for these experiments: enhanced green fluorescent protein (EGFP) as control, wild-type TMC1 (TMC1_WT), and TMC1 deafness (TMC1_dn) that carries a deletion mutation linked to deafness. Using cochlear injectoporation ([@bib40]), these constructs were delivered into wild-type OHCs on postnatal day 3 (P3). The cells were cultured for 1 day in vitro (1DIV) and then analyzed by immunostaining ([Figure 2A](#fig2){ref-type="fig"}) and voltage-clamp recording ([Figure 2B](#fig2){ref-type="fig"}). As revealed by HA antibody, exogenously expressed TMC1 was largely distributed in the soma of OHCs ([Figure 2A](#fig2){ref-type="fig"}), consistent with previous observations ([@bib22]). Overexpression of the EGFP and Tmc1_dn did not affect the I~BG~ (18 pA and 16 pA) ([Figure 2C,D](#fig2){ref-type="fig"}), while the I~BG~ in OHCs overexpressing Tmc1_WT was increased nearly 2.5-fold (43 pA) ([Figure 2C,D](#fig2){ref-type="fig"}). These data indicated that TMC1 functionally contributes a background leak conductance in hair cells.

![TMC1 but not TMC2 conducts the background current.\
(**A**) Exogenous expression of TMC1 in wild-type OHCs from organotypic P3 cochlear tissue cultured for 1 day in vitro (P3 + 1DIV). EGFP was co-expressed as an indicator. The OHCs were stained to show spatial distribution of TMC1 (recognized by HA antibody, red), EGFP (by GFP antibody, green), and actin-enriched stereocilia (by Phalloidin, magenta), with two OHCs from the white dashed frame shown in detail. (**B**) Diagram of the recording configuration. The OHCs expressed engineered TMC1 with EGFP and whole-cell voltage clamped with Cs^+^ in the recording electrode and Na^+^ extracellularly. (**C**) Examples of I~m~ of wild-type OHCs at P3 + 1DIV, expressing control (EGFP), deafness TMC1 (TMC1_dn), or wild-type TMC1 (TMC1_WT). (**D**) Quantification of I~BG~ from wild-type OHCs expressing EGFP, TMC1_dn, and TMC1_WT under conditions similar to those in (**C**). I~BG~ values: EGFP, --17 ± 3 pA; TMC1_dn, --16 ± 3 pA; TMC1_WT, --43 ± 7 pA. (**E**) Representative traces of I~BG~ in P6 *Tmc2*- and *Lhfpl5*-knockout OHCs from acutely dissociated cochleae. (**F**) Quantification of I~BG~ measured from recordings similar to (**E**) from *Tmc2*- and *Lhfpl5*-knockout mice at assigned ages. I~BG~ values: P1 wild-type, --1 ± 0 pA, P1 *Tmc2*-knockout, --0 ± 0 pA; P3 wild-type, --19 ± 4 pA, P3 *Tmc2*-knockout, --26 ± 4 pA; P6 wild-type, --66 ± 5 pA, P6 *Tmc2*-knockout, --73 ± 7 pA, P6 *Lhfpl5*-knockout, --14 ± 2 pA. The external solution contained 1.3 mM Ca^2+^. The holding potential was −70 mV. Data are presented as mean ± SEM. N values are shown in each panel. \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001, one-way ANOVA.\
10.7554/eLife.47441.006Figure 2---source data 1.TMC1 but not TMC2 conducts the background current.](elife-47441-fig2){#fig2}

It has been suggested that TMC2 is closely coupled with TMC1 in MET function. *Tmc2* expression in the cochlea is highest between P1 and P3, then falls after P4 ([@bib22]). Exogenously expressed TMC2 was visibly located in hair bundles of OHCs, as shown by HA tag ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). We further examined the extent to which TMC2 could contribute a background current. Our data showed that the I~BG~ was not altered in *Tmc2*-knockout OHCs at P1, P3, and P6 compared to controls ([Figure 2E,F](#fig2){ref-type="fig"}). Consistently, overexpression of TMC2 did not noticeably change the I~m~ baseline (data not shown). In parallel, we analyzed the I~BG~ in *Lhfpl5*-knockout OHCs. Interestingly, similar to *Tmc1*-knockout, there was no evident I~BG~ in *Lhfpl5*-knockout OHCs ([Figure 2E,F](#fig2){ref-type="fig"}), consistent with the previous findings that LHFPL5 and TMC1 function in a common pathway ([@bib7]; [@bib39]).

TMC1-mediated leak current is not carried by the resting open MET channel {#s2-2}
-------------------------------------------------------------------------

Because of existing tension in the hair bundle, the open probability of MET channels at rest in hair cells is significant ([@bib1]; [@bib10]; [@bib21]). Thus, the I~BG~ may come from the resting MET current. To determine the relationship between I~BG~ and resting MET current, we analyzed the leak current during mechanical closure of hair bundles or in the presence of the MET channel blocker dihydrostreptomycin (DHS) ([Figure 3A](#fig3){ref-type="fig"}). As conductance through the MET channel is enhanced when the external Ca^2+^ concentration is low, we carried out the experiments in 0.3 mM Ca^2+^ to increase the readout of the leak current. A sinusoidal fluid jet deflected the hair bundle back and forth to open and close the MET channels ([Figure 3A](#fig3){ref-type="fig"}, inset). The I~m~ was 98 pA at rest ([Figure 3A,B](#fig3){ref-type="fig"}), while the I~m~ was 45 pA at fluid-jet-closed status ([Figure 3B](#fig3){ref-type="fig"}, \#1). When OHC was perfused with solution containing 144 mM Na and 100 μM DHS (144 Na + 0.1 DHS), the current (I~DHS~) was 55 pA ([Figure 3B](#fig3){ref-type="fig"}, \#2 and \#3). Moreover, the I~NMDG~ was near zero when switching to 144 NMDG solution ([Figure 3B](#fig3){ref-type="fig"}, \#3), from which I~Leak~ was defined as MET-independent leak current by subtracting I~DHS~ from I~NMDG~. Thus, the I~Leak~ persisted in either mechanical closure or pharmacological blockade of the MET channel ([Figure 3C](#fig3){ref-type="fig"}). We further examined the proportion of I~Leak~ in I~BG~ at different Ca^2+^ concentrations, which became a major part of I~BG~ when \[Ca^2+^\]~o~ was 1.3 mM and larger ([Figure 3D](#fig3){ref-type="fig"}). In general, the I~Leak~ in 1.3 mM \[Ca^2+^\]~o~ was −51 pA in P6 wild-type OHCs and −17 pA in P6 *Tmc1*-knockout OHCs ([Figure 3E](#fig3){ref-type="fig"}), by subtracting currents recorded in 144 NMDG and 144 Na + 0.1 DHS. In the following experiments, we present the I~Leak~ in 1.3 mM \[Ca^2+^\]~o~ as most of the measured membrane currents.

![TMC1-mediated leak current is not carried by the resting open MET channel.\
(**A**) Representative I~m~ trace showing fluid jet (FJ)-induced open and closed status of MET current and DHS-induced alteration of baseline current. The OHCs were bathed in external solution with 0.3 mM Ca^2+^ instead of 1.3 mM Ca^2+^. Insets: left, a diagram of fluid jet stimulation on a hair bundle; right, a 40 Hz sinusoidal stimulation protocol was used to induce forward and reverse deflection of the hair bundle. (**B**) Dashed frames \#1, \#2, and \#3 in (**A**) are shown as enlarged traces. The baseline current was similar when the MET channels were closed by either FJ (\#1) or DHS (I~DHS~, \#2), as highlighted with a red dashed line. As shown in \#3, the DHS-sensitive resting MET current (I~Resting-MET~) was calculated by subtraction of I~Na~ and I~DHS~. The baseline current was further closed by NMDG (I~NMDG~). I~Leak~ was defined as the subtraction of I~DHS~ and I~NMDG~. (**C**) Quantification of subtracted currents under different conditions: background, --113 ± 7 pA; FJ-NMDG (I~Leak~ subtracted from current baseline closed at negative FJ), --72 ± 6 pA; DHS-NMDG (I~Leak~ subtracted from that closed by 100 μM DHS), --65 ± 6 pA. (**D**) Quantification of ratio of I~Leak~ to I~BG~ (I~Leak~/I~BG~) under different \[Ca^2+^\]~o~ conditions: 0.1 mM, 0.29 ± 0.04; 0.3 mM, 0.45 ± 0.05; 0.5 mM, 0.47 ± 0.07; 1.3 mM, 1.00 ± 0.03; 3.0 mM, 0.96 ± 0.03. (**E**) Quantification of the I~Leak~ of OHCs measured in 1.3 \[Ca^2+^\]~o~. Wild-type I~Leak~, --51 ± 3 pA, *Tmc1*-knockout I~Leak~, --17 ± 2 pA. The external solution contained variable Ca^2+^ concentration as indicated. The holding potential was −70 mV. Data are represented as mean ± SEM. N values are shown in each panel. \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001, (**C**) ANOVA; (**E**) Student's t-test.\
10.7554/eLife.47441.009Figure 3---source data 1.TMC1-mediated leak current is not carried by the resting open MET channel.](elife-47441-fig3){#fig3}

We queried where the I~Leak~ comes from, hair bundle or soma. This question was examined by whole-cell voltage-clamp recordings in wild-type OHCs after removing the hair bundles ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). Compared to the I~Leak~ recorded from hair-bundle preserved OHCs (48 pA), the I~Leak~ from hair-bundle removed OHCs was much smaller (10 pA). This result suggests that the leak channels mostly function in hair bundles.

Amino-acid substitutions in TMC1 alter the TMC1-mediated leak current {#s2-3}
---------------------------------------------------------------------

We next addressed whether essential amino acids of TMC1 affect the leak channel. It has been reported that six amino acids in TMC1 are critical for MET channel function by affecting the pore properties of the channel ([@bib31]) ([Figure 4A](#fig4){ref-type="fig"}). We replaced these six amino acids with cysteine, as reported by [@bib31], and expressed the mutations in *Tmc1*-knockout OHCs by injectoporation to assess the effects on the leak current ([Figure 4B](#fig4){ref-type="fig"}). As controls, we used TMC1_WT and TMC1_dn, and found that the I~Leak~ in *Tmc1*-knockout OHCs at P3+1DIV was restored by TMC1_WT but not by TMC1_dn ([Figure 4C,D](#fig4){ref-type="fig"}). Among the cysteine-substituted TMC1 constructs, five out of the six amino acids failed to restore the leak current. Especially the G411C, N447C, D528C, and D569C mutations nearly abolished the I~Leak~, while T532C partially restored it. Surprisingly, M412C, which has been linked to deafness in Beethoven mice ([@bib34]), behaved like wild-type TMC1.

![Amino-acid substitution in TMC1 alters the leak current.\
(**A**) TMC1 with 10 putative transmembrane domains. The six substituted amino acids are highlighted as colored balls in the predicted positions, and the deafness (dn) truncation is at the third extracellular loop between TM5 and TM6. (**B**) Diagram of the analysis of leak current in cultured *Tmc1*-knockout OHCs (P3 + 1 DIV) expressing modified TMC1 (TMC1\*). (**C**) Representative traces showing the rescue of leak conductance in OHCs by control full-length TMC1 (TMC1_WT), deafness TMC1 (TMC1_dn), TMC1-G411C (G411C), TMC1-M412C (M412C), TMC1-N447C (N447C), TMC1-D528C (D528C), TMC1-T532C (T532C), and TMC1-D569C (D569C). Perfusion contents are indicated below. An 800 nm step deflection was applied to the hair bundle every 10 s by a glass probe. The glass probe induced MET currents are marked '+\', accompanying unwanted MET currents and electrical artefacts induced by switching the perfusion system (\#). Note that the MET current was truncated to better show the leak current. (**D**) Quantification of rescue by mTMC1 constructs. I~Leak~ values: TMC1_WT, --49 ± 5 pA, G411C, --23 ± 3 pA; M412C, --40 ± 6 pA, N447C, --15 ± 1 pA; D528C, --22 ± 4 pA, T532C, --32 ± 4 pA, D569C, --23 ± 3 pA, TMC1_dn, --18 ± 3 pA. The rescue indexes of FL and dn were used to evaluate significant difference. Cell numbers are shown on each bar. The external solution contained 1.3 mM Ca^2+^. The holding potential was −70 mV. Data are presented as mean ± SEM. \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001, ANOVA.\
10.7554/eLife.47441.013Figure 4---source data 1.Amino-acid substitution in TMC1 alters the leak current.](elife-47441-fig4){#fig4}

Treatment with MTSET (2-(trimethylammonium)ethyl methanethiosulfonate, bromide) did not, however, change the current baseline in OHCs when expressing any of the six cysteine-substituted TMC1 constructs ([Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}). This was not because of the insensitivity of cysteine, or a weak MTSET effect, because MTSET treatment did change the MET current amplitude in *Tmc1;Tmc2* double-knockout OHCs expressing M412C ([Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}) as previously reported ([@bib31]). The cysteine replacement did not show a consistent pattern of modulation of the leak current or the MET current ([Figure 4---figure supplement 1C](#fig4s1){ref-type="fig"}), implying that different molecular mechanisms underlie the two types of current.

Pharmacological blockade of the TMC1-mediated leak conductance {#s2-4}
--------------------------------------------------------------

Next, we set out to evaluate the properties of the leak current by further analyzing its response to pharmacological inhibitors of the MET channel. We first examined the inhibitory effects of the commonly used MET channel blockers DHS, d-tubocurarine (dTC), and amiloride ([Figure 5A--D](#fig5){ref-type="fig"}). DHS had no blocking effect on the current baseline at a working concentration (100 μM) that blocks MET channels ([Figure 5A,B](#fig5){ref-type="fig"}). However, the background conductance was 50% inhibited at 487 μM DHS from the fit, 30-times the IC~50~ of the MET channel ([Figure 5A,B](#fig5){ref-type="fig"}), and dTC and amiloride also affected the leak current, albeit at higher concentrations than the MET current ([Figure 5C,D](#fig5){ref-type="fig"}).

![TMC1-mediated leak conductance is antagonized by MET channel blockers.\
(**A and B**) Representative trace (**A**) and statistical curve (**B**) of I~m~ inhibition by DHS. A 10 Hz train of 800 nm step deflection was applied to the hair bundle by a glass probe to induce MET currents. I~MET~ and I~BG~ were calculated and plotted against the DHS concentration. As fitted, the IC~50~ of DHS was 15 μM for the MET channels and 487 μM for the leak conductance. Cell numbers, 7--11. Hill slope: I~MET~, −1.10; I~BG~, −0.65. (**C and D**) Statistical dose curve of I~m~ with graded concentrations of d-tubocurarine (dTC) (**C**) and amiloride (**D**). dTC IC~50~: I~MET~, 6 μM; I~BG~, 82 μM. dTC Hill slope: I~MET~, −0.47; I~BG~, −2.80. dTC cell numbers, 5--15. Amiloride IC~50~: I~MET~, 46 μM; I~BG~, 365 μM. Amiloride Hill slope: I~MET~, −1.36; I~BG~, −1.67. Amiloride cell numbers, 7--16. (**E and F**) Dosage effect of Gd^3+^. Example trace (**E**) and statistical curve (**F**) of I~m~ in OHCs during perfusion with solutions containing graded concentrations of Gd^3+^. A train of 800 nm step deflection was applied to the hair bundle by a glass probe to induce MET currents. The MET and leak current amplitudes changed because of the channel sensitivity of Gd^3+^ and NMDG. IC~50~: I~MET~, 66 μM; I~BG~, 524 μM. Hill slope: I~MET~, −0.48; I~BG~, −2.49. Cell numbers, 7--16. (**G and H**) Dose effect of La^3+^. Example trace (**G**) and dosage curve (**H**) of I~m~ with La^3+^ treatment. A train of 800 nm step deflection was applied to the hair bundle by a glass probe to induce MET currents. IC~50~: I~MET~, 259 μM; I~BG~, 531 μM. Hill slope: I~MET~, −1.06; I~BG~, −5.67. Cell numbers, 7--8. For space reasons, 144 NMDG is shown as 0 Na. The external solution contained 1.3 mM Ca^2+^. The holding potential was −70 mV. Data are presented as mean ± SEM.\
10.7554/eLife.47441.016Figure 5---source data 1.TMC1-mediated leak conductance is antagonized by MET channel blockers.](elife-47441-fig5){#fig5}

It has been reported that trivalent cations such as Gd^3+^ and La^3+^, block MET channels ([@bib17]; [@bib25]), so we applied Gd^3+^ and La^3+^ at various concentrations and monitored the inhibitory effects on evoked MET current as well as leak current ([Figure 5E--H](#fig5){ref-type="fig"}). Surprisingly, the leak current was not affected even when \[Gd^3+^\]~o~ reached 80 μM, the IC~50~ for blocking the MET current ([Figure 5E,F](#fig5){ref-type="fig"}). However, the leak current was inhibited by \[Gd^3+^\]~o~ with an IC~50~ of 541 μM ([Figure 5E,F](#fig5){ref-type="fig"}). Similarly, \[La^3+^\]~o~ inhibited the MET channel with an IC~50~ of 259 μM and the leak current with an IC~50~ of 531 μM ([Figure 5G,H](#fig5){ref-type="fig"}). It is noteworthy that the I~BG~ included the I~Resting-MET~ and the I~Leak~ when the concentration of the blockers was low, but the I~BG~ was mainly composed of the I~Leak~ when the concentration of blockers was high enough ([Figure 5](#fig5){ref-type="fig"}).

Ionic permeability of the TMC1-mediated leak conductance {#s2-5}
--------------------------------------------------------

To further characterize the leak current in OHCs, we carried out a series of ion-permeation tests using the cations Li^+^, Cs^+^, Ba^2+^, Zn^2+^, Co^2+^, Mg^2+^, and Ca^2+^ ([Figure 6A,B](#fig6){ref-type="fig"}). Most of the cations shared a size of I~Leak~ similar to Na^+^, except for Cs^+^ and Ca^2+^ ([Figure 6A,B](#fig6){ref-type="fig"}). The Cs^+^-conducted I~Leak~ was slightly larger ([Figure 6A](#fig6){ref-type="fig"}), while 75 mM Ca^2+^ robustly blocked the I~Leak~ ([Figure 6B](#fig6){ref-type="fig"}). The Ca^2+^ permeability of the leak channel was further determined from calculation of reversal potentials by a voltage ramp stimulation with Ca^2+^ and DHS extracellularly and Cs^+^ intracellularly ([Figure 6C](#fig6){ref-type="fig"}). Compared to Na^+^ and Mg^2+^ permeability, the Ca^2+^ likely provided an inhibition function on the leak channel ([Figure 6D](#fig6){ref-type="fig"}), which is different with the Ca^2+^ permeability of the MET channel (around six for P~Ca~/P~Cs~ at P5 apical OHCs) ([@bib24]). Next, we monitored the background and MET currents in solutions containing different concentrations of Ca^2+^ and Na^+^. Results showed that the leak current was highly sensitive to Ca^2+^; increasing when \[Ca^2+^\]~o~ declined, and inversely, decreasing when \[Ca^2+^\]~o~ escalated ([Figure 6E,F](#fig6){ref-type="fig"}). The MET current was initially reduced following the increase of \[Ca^2+^\]~o~, and reached a plateau after \[Ca^2+^\]~o~ was at least \>10 mM ([Figure 6E,F](#fig6){ref-type="fig"}), by which the concentration was sufficient enough to block the leak current to an extent similar to that observed in *Tmc1*-knockout OHCs ([Figure 6G](#fig6){ref-type="fig"}).

![High-concentration Ca^2+^ blocks the leak current but not MET current.\
(**A**) Monovalent cations Li^+^ and Cs^+^ conducted the leak current. In this experiment, 150 mM NaCl was substituted with 150 mM LiCl or 150 mM CsCl in the external solution. (**B**) Divalent cations 10 mM Ba^2+^, 75 mM Zn^2+^, 75 mM Co^2+^, 150 mM Mg^2+^, and 75 mM Ca^2+^, conducted the leak current. The 150 mM NaCl was partially or completely replaced with cations as described in the Materials and methods. (**C**) Representative I~m~ traces by ramp stimulation for calculation of ionic permeability of the leak channel. The extracellular ion was switched from 150 mM Na^+^ to 75 mM Ca^2+^, and to 150 NMDG^+^, all containing 100 μM DHS. In the intracellular solution, 150 mM CsCl was used. (**D**) Quantification of ionic permeability calculated from similar recordings in (**C**). (**E**) Example trace of I~m~ of OHCs during perfusion with solutions containing graded concentrations of Ca^2+^ and Na^+^. An 800 nm step deflection was applied to the hair bundle by a glass probe. The glass probe induced MET currents are marked '+\', accompanying unwanted MET currents and artefacts induced by switching the perfusion system (\#). (**F**) Dose curves of I~BG~ and I~MET~ in wild-type OHCs in different Ca^2+^ and Na^+^ concentrations (cell numbers, 9--20). (**G**) Quantification of dose-dependent background leak current in OHCs from wild-type (black) and *Tmc1*-knockout (red) mice when bathed in mixed Ca^2+^ and Na^+^. The ions and concentrations used in test external solutions were variable, as described in this figure legend and the Materials and methods. The holding potential was −70 mV. Data are presented as mean ± SEM. N values are shown in each panel. \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001, (**B,D**) ANOVA.\
10.7554/eLife.47441.018Figure 6---source data 1.High-concentration Ca^2+^ blocks the leak current but not MET current.](elife-47441-fig6){#fig6}

The leak current modulates action potential firing in IHCs {#s2-6}
----------------------------------------------------------

Next, we investigated the physiological relevance of the TMC1-mediated background conductance in auditory transduction. A significant leak conductance would be expected to depolarize the membrane and affect cell excitability. IHCs are innervated by the spiral ganglion neurons that transmit sound information to the CNS, and signal transmission from hair cells to the spiral ganglion; therefore possibly being affected by the leak conductance. Therefore, we measured the membrane potential (V~m~) in IHCs bathed in external solution with 100 μM DHS by whole-cell current-clamp recording ([Figure 7A](#fig7){ref-type="fig"}). In wild-type IHCs, the resting V~m~ varied (actively and periodically) in bursting and non-bursting states ([Figure 7A](#fig7){ref-type="fig"}). However, the resting V~m~ was more hyperpolarized, and there was limited action potential firing in *Tmc1*-knockout IHCs ([Figure 7A](#fig7){ref-type="fig"}). With positive current injection, the *Tmc1*-knockout IHCs fired action potentials at threshold similar to wild-type IHCs ([Figure 7A](#fig7){ref-type="fig"}). Although the V~m~ baseline in the non-bursting state was more hyperpolarized in wild-type IHCs, it was still more depolarized than the V~m~ baseline in *Tmc1*-knockout IHCs ([Figure 7A,B](#fig7){ref-type="fig"}). This change of membrane excitability was also determined by monitoring the action potential bursting rate ([Figure 7C](#fig7){ref-type="fig"}) and the leak current ([Figure 7D](#fig7){ref-type="fig"}). We found that the leak current was smaller in IHCs than that in OHCs, which may be because of a different expression profile of potassium channels ([@bib29]; [@bib28]). Results also showed that, with ramp current injection, the firing threshold was similar, but the minimum injected current required to induce firing in *Tmc1*-knockout IHCs was \~20 pA greater than that in wild-type IHCs ([Figure 7E,G,H](#fig7){ref-type="fig"}). When depolarized by stepped current injection, the firing rate was lower in *Tmc1*-knockout IHCs and the rate-current curve was shifted to the right but finally reached a similar level when a larger current was injected ([Figure 7F,I](#fig7){ref-type="fig"}).

![IHC excitability is down-regulated in *Tmc1*-knockout mice.\
(**A**) Representative current-clamp recording in IHCs bathed in external solution with 100 μM DHS from wild-type (black) and *Tmc1*-knockout (red) mice. For the most part, the IHCs were held at 0 pA. To define excitability, a ramp current was injected into the *Tmc1*-knockout IHCs to induce a burst of spikes. (**B**) Quantification of V~m~ recorded in IHCs similar to (**A**). Values of V~m~ in wild-type IHCs were defined as two states, bursting and non-bursting, which did not apply to *Tmc1*-knockout IHCs. V~m~ of wild-type in bursting state, 49 ± 2 mV; wild-type in non-bursting state, 60 ± 2 mV; *Tmc1*-knockout, 73 ± 2 mV. (**C**) Quantification of firing rate (spikes/s) in IHCs similar to (**A**). Values of firing rate: wild-type, 3.2 ± 0.7 Hz; *Tmc1*-knockout, 0 ± 0 Hz. (**D**) Quantification of I~Leak~ from voltage-clamp recording in IHCs. Values of I~Leak~: wild-type, 24 ± 4 pA; *Tmc1*-knockout, 14 ± 2 pA. (**E**) Representative current-clamp traces of V~m~ in IHCs with ramp-current injection from --100 pA to +100 pA for 3 s. (**F**) Representative current-clamp recording in IHCs stimulated by a family of depolarization currents from --50 pA to +125 pA at 25 pA steps. (**G**) Quantification of firing threshold from data as in (**E**). Values of threshold were --47 ± 1 mV in wild-type OHCs and --47 ± 1 mV in *Tmc1*-knockout OHCs. (**H**) Quantification of minimum current injected (Injected I~min~) to evoke an action potential from data as in (**E**). In wild-type OHCs: --0 ± 7 pA; in *Tmc1*-knockout OHCs: --21 ± 4 pA. (**I**) Quantification of numbers of spikes per second from data as in (**F**). Wild-type: 0 pA, 1.3 ± 0.7; 25 pA, 9.1 ± 0.8; 50 pA, 12.3 ± 0.7; 75 pA, 13.1 ± 0.7, 100 pA, 13.3 ± 0.6; 125 pA, 13.6 ± 0.7. *Tmc1*-knockout: 0 pA, 0 ± 0; 25 pA, 5.1 ± 1.3; 50 pA, 10.6 ± 1.1; 75 pA, 12.7 ± 0.7, 100 pA, 13.0 ± 0.9; 125 pA, 13.2 ± 1.1. In this figure, the external solution contained 1.3 mM Ca^2+^ and 100 μM DHS. K^+^ was used in the intracellular solution for current-clamp recordings in this figure except that Cs^+^ was used for voltage-clamp recording in (**D**). Data are presented as mean ± SEM. N values are shown in each panel. \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001, (**B**) ANOVA; (**C,D,G,H,I**) Student's t-test.\
10.7554/eLife.47441.020Figure 7---source data 1.IHC excitability is down-regulated in *Tmc1*-knockout mice.](elife-47441-fig7){#fig7}

The leak current follows the tonotopic gradient of the MET response in OHCs {#s2-7}
---------------------------------------------------------------------------

The MET currents increase in OHCs from apex to base, which is considered as a manifestation of cochlear tonotopy. First, we examined the I~Leak~ in OHCs along the cochlear coil ([Figure 8A](#fig8){ref-type="fig"}). As anticipated, we found a gradient in the leak current in wild-type OHCs, while the gradient was abolished in *Tmc1*-knockout OHCs ([Figure 8B,C](#fig8){ref-type="fig"}). We next analyzed the MET current along the cochlear coil when blocking the leak current with 35 mM \[Ca^2+^\]~o~, as 35 mM \[Ca^2+^\]~o~ was sufficient to block the leak current to an extent similar to TMC1 removal in OHCs ([Figure 6G](#fig6){ref-type="fig"}). Strikingly, the gradual increase in MET current amplitude was severely blunted in OHCs in the presence of 35 mM \[Ca^2+^\]~o~ ([Figure 8D,E](#fig8){ref-type="fig"}). Consistently, the OHCs lacking TMC1 lost the gradient of the MET currents as previously reported ([@bib5]) and we observed ([Figure 8D,E](#fig8){ref-type="fig"}). These data suggest that the tonotopic properties of the TMC1-participated leak channel and MET channel in OHCs could be modulated by external Ca^2+^. The leak and MET current decreased from apex to base in *Tmc1*-knockout OHCs, which may correlate with the graded expression level of TMC1 along the cochlear coil. We further questioned temporal correlation of TMC1 and the leak conductance as* Tmc1* expression starts to increase from P3 and reaches a plateau in adult mice ([@bib22]). We therefore investigated how the leak current changed in ageing OHCs before MET maturation (P3) and after the onset of hearing (P14). We found that the leak current amplitude increased from P3 to P6, and to P14 ([Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}).

![TMC1-mediated leak and MET currents in OHCs.\
(**A**) Diagram showing the tonotopic map in mouse hair cells (adapted from Figure 1B in [@bib24]), labeled with response frequencies (kHz, gray) and location (D% to apex, black). The apex and base are defined as 0 and 1, with reference to which D05, D20, D40, D60, and D80 represent distances of 0.05, 0.2, 0.4, 0.6, and 0.8. (**B**) Representative traces of I~m~ recorded in OHCs at different locations along the cochlear coil, from wild-type (black) and *Tmc1*-knockout (red) mice. The external solution contained 1.3 mM Ca^2+^. The apex and base are defined as 0 and 1, with reference to which D05, D20, D40, and D60 represent distances of 0.05, 0.2, 0.4, and 0.6. (**C**) Quantification of location-specific I~Leak~ from similar recordings to those in (**B**). Values of I~Leak~ in wild-type OHCs (pA): D05, --23 ± 4; D20, --63 ± 4; D40, --67 ± 7; D60, --84 ± 7. I~Leak~ values in *Tmc1*-knockout OHCs (pA): D05, --18 ± 3; D20, --18 ± 2; D40, --10 ± 2; D60, --5 ± 1. (**D**) Representative traces of location-specific MET current in wild-type OHCs when bathed in 1.3 mM or 35 mM Ca^2+^ and *Tmc1*-knockout OHCs when bathed in 1.3 mM Ca^2+^. A sinusoidal deflection was applied to the hair bundle by a fluid jet. (**E**) Quantification of location-specific macroscopic MET current. Values of I~MET~ in wild-type OHCs in 1.3 mM Ca^2+^ (pA): D05, --505 ± 37 pA; D20, --780 ± 24 pA; D40, --872 ± 21 pA; D80, --939 ± 22 pA. Values of I~MET~ in wild-type OHCs in 35 mM Ca^2+^ (pA): D05, --369 ± 13 pA; D20, --369 ± 13 pA; D40, --384 ± 30 pA; D60, --461 ± 31 pA. Values of I~MET~ in *Tmc1*-knockout OHCs in 1.3 mM Ca^2+^ (pA): D20, --371 ± 35 pA; D40, --177 ± 19 pA; D60, --117 ± 15 pA; D80, --102 ± 9 pA. The holding potential was −70 mV. In (**C**) and (**E**), data are presented as mean ± SEM with N values. \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001, ANOVA.\
10.7554/eLife.47441.023Figure 8---source data 1.TMC1-mediated leak and MET currents in OHCs.](elife-47441-fig8){#fig8}

We next determined whether the change in macroscopic MET current represents a change in the unitary MET channel conductance, and whether the absence of the leak current disrupts the tonotopic gradient. The unitary MET channel analysis showed that 35 mM \[Ca^2+^\]~o~ reduced the unitary MET channel current to \~5 pA in both low-frequency and high-frequency OHCs ([Figure 9A,B](#fig9){ref-type="fig"}). These data further suggest that the extracellular Ca^2+^ modulates leak conductance and MET channel properties, accordingly.

![High Ca^2+^ removes the MET conductance gradient as revealed by unitary channel analysis.\
(**A**) Location-specific single MET channel recording from wild-type OHCs in solution with 3 mM or 35 mM Ca^2+^ at D05 or D60. The traces were chosen to show nice dual-peak fitting but did not represent normal flickers. A 100 nm step deflection was applied to the hair bundle by a glass probe. (**B**) Statistical analysis of location-specific unitary MET channel current. Values of unitary I~MET~ in 3 mM Ca^2+^: D05, --7.0 ± 0.2 pA; D20, --7.9 ± 0.2 pA; D60, --10.6 ± 0.2 pA. Values of I~MET~ in 35 mM Ca^2+^: D05, --4.7 ± 0.1 pA; D20, --4.8 ± 0.1 pA; D60, --4.9 ± 0.1 pA. The holding potential was −70 mV. N values are shown as events/cells. Data are presented as mean ± SEM. \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001, ANOVA.\
10.7554/eLife.47441.026Figure 9---source data 1.High Ca^2+^ removes the MET conductance gradient as revealed by unitary channel analysis.](elife-47441-fig9){#fig9}

Discussion {#s3}
==========

Our research demonstrated that in mouse hair cells, besides its function in MET, TMC1 is essential for a leak conductance ([Figures 1](#fig1){ref-type="fig"}--[3](#fig3){ref-type="fig"}). As shown by the mutagenesis experiments ([Figure 4](#fig4){ref-type="fig"}), at least four amino acids were critical for the leak conductance, as these constructs failed to restore the leak current after replacement of a single amino acid by cysteine. In addition, the leak conductance was inhibited by typical MET channel blockers, implying that TMC1 is the responsible component for the leak current ([Figure 5](#fig5){ref-type="fig"}). With TMC1 deficiency, the resting membrane potential was hyperpolarized, resulting in the absence of the spontaneous action potential firing in neonatal IHCs ([Figure 7](#fig7){ref-type="fig"}), and the removal of the leak conductance was coupled with abolishment of the gradient of MET conductances in OHCs ([Figures 8](#fig8){ref-type="fig"} and [9](#fig9){ref-type="fig"}). All these data pointed out a previously unappreciated non-MET role of TMC1 in mammals, by mediating a leak conductance and thereby participating tonotopy and regulating membrane excitability.

It has been recognized that leak conductance is generally used in the nervous system to regulate neuronal excitability and thus circuit activity; it recruits a variety of channels on the plasma membrane or endoplasmic reticulum ([@bib3]; [@bib16]; [@bib27]). In other species, TMC orthologues function in diverse ways according to their expression pattern in effector cells ([@bib18]; [@bib19]; [@bib36]; [@bib42]; [@bib43]; [@bib44]). Hence, our results strongly support the hypothesis that the excitability of cells and neural circuits that control processes from sensory transduction to motor function are commonly upregulated by TMC proteins in diverse organisms.

Of interest, the leak conductance differed from the MET conductance in several properties, although both are functional representations of TMC1. First, the leak current did not stem from the resting open MET channels ([Figure 3](#fig3){ref-type="fig"}). Second, the patterns of conductance change differed for the leak channel and the MET channel according to the amino-acid substitution experiment. Further, adding positive charge to these amino acids did not affect the leak conductance, as revealed by its insensitivity to treatment with MTSET ([Figure 4](#fig4){ref-type="fig"} and [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}), which was not identical to the effect on the MET conductance ([@bib31]). An intriguing observation was that M412C did not disrupt the leak conductance with or without MTSET. Inversely though, previous evidence has shown that MTSET treatment of M412C reduced the MET current ([@bib31]). In terms of the leak conductance, M412C behaved similarly to wild-type, which is not surprising, as studies have shown the distinct sensitivities of the leak and MET conductances to factors including channel blockers and calcium ([Figures 5](#fig5){ref-type="fig"} and [6](#fig6){ref-type="fig"}), and M412K causes deafness without affecting the MET current in Beethoven mice ([@bib29]). Third, the leak channel shared a group of identical antagonists with the MET channel but had different blocking affinity ([Figure 5](#fig5){ref-type="fig"}). Both MET channel blockers, ([Figure 5A--D](#fig5){ref-type="fig"}) and non-selective cation channel blockers ([Figure 5E--H](#fig5){ref-type="fig"}) inhibited the leak current but with an IC~50~5--10-fold higher than that for the MET channel. Last, extracellular high Ca^2+^ blocked the leak conductance but not the MET channel ([Figure 6](#fig6){ref-type="fig"}). These lines of evidence indicate that TMC1 confers the leak conductance by a mechanism distinct from the MET channel.

The tonotopic gradient of conductance in OHCs is an important property of hair-cell MET ([@bib4]; [@bib32]; [@bib35]). Interestingly, the TMC1-mediated leak conductance exhibits a tonotopic pattern in OHCs, in parallel with the tonotopicity of the MET current. The leak current still existed in *Tmc2*-knockout OHCs, but it was absent from *Tmc1*- or *Lhfpl5*-knockout OHCs ([Figure 2E,F](#fig2){ref-type="fig"}), which is consistent with the findings that the gradient of the MET response was lost in *Tmc1*- and *Lhfpl5*-knockout mice and preserved in *Tmc2*-deficient mice ([@bib7]). The leak conductance and the MET conductance increased in wild-type OHCs but decreased in *Tmc1*-knockout OHCs along the cochlear coil ([Figure 8A,B](#fig8){ref-type="fig"}), which also coincides with the spatiotemporal *Tmc1* expression pattern ([@bib22]) and the abundance of TMC1 proteins in graded numbers ([@bib8]). However, high \[Ca^2+^\]~o~ abolished both the leak current and the gradient of the MET response, defined by the analysis of the macroscopic MET current ([Figure 8](#fig8){ref-type="fig"}) and unitary MET current ([Figure 9](#fig9){ref-type="fig"}), which reflected different working mechanisms of the MET channel and the leak channel to \[Ca^2+^\]~o~. Our results showed thatthe leak conductance, together with the MET response, is tuned by extracellular Ca^2+^ and other unknown determinants, which is not surprising as other factors, such as PIP2, also regulate MET channel pore properties ([@bib15]).

Because of limited information about the structure of TMC1, we do not yet know how TMC1 confers the leak conductance, at least it appears that the leak channel is located in the hair bundle ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). It was proposed that there are increasing numbers of TMC molecules (from 8 to 20) per MET site from low-frequency OHCs to high-frequency OHCs ([@bib8]). However, not all TMC1 proteins are localized at the MET site, where only up to two MET channel complexes exist ([@bib8]; [@bib4]; [@bib26]). Our data further describe a scenario that extra TMC1 proteins functionally couple with the leak channels with graded conductances in OHCs along the cochlear coil, coinciding with increased numbers of extra TMC1 molecules that are not at the MET site per hair bundle from apex to base ([@bib8]). Hence, we suggest a working model in which TMC1 functionally incorporates into a leak channel and the MET channel, rather than being the pore of the two channels, and tunes the activity of hair cells. However, this hypothesis needs to be further examined by structural and functional studies.

Materials and methods {#s4}
=====================

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                                Designation                                                       Source or reference                                                  Identifiers                                                                                           Additional\
  (species) or resource                                                                                                                                                                                                                                                                     information
  -------------------------------------------- ----------------------------------------------------------------- -------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------- ---------------------------------------------------
  Gene (*Mus musculus*)                        [TMC1](https://www.ncbi.nlm.nih.gov/gene/?term=13409)             NCBI\                                                                                                                                                                      
                                                                                                                 ID: 13409                                                                                                                                                                  

  Gene (*Mus musculus*)                        [TMC2](https://www.ncbi.nlm.nih.gov/gene/?term=192140%5Buid%5D)   NCBI ID:192140                                                                                                                                                             

  Gene (*Mus musculus*)                        [Lhfpl5](https://www.ncbi.nlm.nih.gov/gene/328789)                NCBI\                                                                                                                                                                      
                                                                                                                 ID: 328789                                                                                                                                                                 

  Strain, strain background (*Mus musculus*)   C57BL6                                                            Vitalriver                                                                                                                                                                 

  Genetic reagent (*Mus musculus*)             C57BL6\                                                           [MGI: J:184419](http://www.informatics.jax.org/reference/J:184419)   Griffith AJ etc.                                                                                      From JAX
                                               TMC1 knockout                                                                                                                                                                                                                                

  Genetic reagent (*Mus musculus*)             C57BL6\                                                           [MGI: J:184419](http://www.informatics.jax.org/reference/J:184419)   Griffith AJ etc.                                                                                      From JAX
                                               TMC2 knockout                                                                                                                                                                                                                                

  Genetic reagent (*Mus musculus*)             C57BL6\                                                           [MGI: J:98396](http://www.informatics.jax.org/reference/J:98396)     Johnson KR etc.                                                                                       From JAX
                                               [Lhfpl5](https://www.ncbi.nlm.nih.gov/gene/328789) knockout                                                                                                                                                                                  

  Antibody                                     Chicken anti-GFP                                                  aveslab                                                              RRID:[AB_10000240](https://scicrunch.org/scicrunch/resolver/AB_10000240?i=5c996e0a48735f20ec43b24b)   Cat:GFP-1020\
                                                                                                                                                                                                                                                                                            (1:1000)

  Antibody                                     Anti-mouse HA Clone 16B12                                         Biolegend                                                            RRID:[AB_2565335](https://scicrunch.org/resolver/AB_2565335)                                          Cat:901513\
                                                                                                                                                                                                                                                                                            (1:500)

  Antibody                                     Alexa FluroTM 488 goat anti-chicken IgG(H+L)                      Invitrogen                                                           RRID:[AB_142924](https://scicrunch.org/resolver/AB_142924)                                            Cat: A-11039\
                                                                                                                                                                                                                                                                                            Lot:1937504\
                                                                                                                                                                                                                                                                                            (1:2000)

  Antibody                                     Alexa FluroTM 568 goat anti-mouse IgG(H+L)                        Invitrogen                                                           RRID:[AB_2534072](https://scicrunch.org/resolver/AB_2534072)                                          Cat: A-11004\
                                                                                                                                                                                                                                                                                            Lot:2014175\
                                                                                                                                                                                                                                                                                            (1:1000)

  Sequence-based reagent                       TMC1-DF-F                                                         Ruibio\                                                              This paper                                                                                            5':tgagattaacaacaaggaat tcgtgcgtctcaccgttt
                                                                                                                 Tech                                                                                                                                                                       

  Sequence-based reagent                       TMC1-DF-R                                                         Ruibio\                                                              This paper                                                                                            5':tgagacgcacgaattcctt gttgttaatctcatccatcaaggc
                                                                                                                 Tech                                                                                                                                                                       

  Sequence-based reagent                       mTMC1-G411C-F                                                     Ruibio\                                                              This paper                                                                                            5': aatgtccctcctgTGTatgtt ctgtcccaccctgtttga
                                                                                                                 Tech                                                                                                                                                                       

  Sequence-based reagent                       mTMC1-G411C-R                                                     Ruibio\                                                              This paper                                                                                            5':ACAcaggagggacattacc atgttcatttcatttttttcccacca
                                                                                                                 Tech                                                                                                                                                                       

  Sequence-based reagent                       mTMC1-M412C-F                                                     Ruibio\                                                              This paper                                                                                            \
                                                                                                                 Tech                                                                                                                                                                       5':gtccctcctggggTGTttc tgtcccaccctgtttgactt

  Sequence-based reagent                       mTMC1-M412C-R                                                     Ruibio\                                                              This paper                                                                                            5':ACAccccaggagggacatt accatgttcatttcatttttttccca
                                                                                                                 Tech                                                                                                                                                                       

  Sequence-based reagent                       mTMC1-N447C-F                                                     Ruibio\                                                              This paper                                                                                            5':tcttcttctaggcTGTttg tatgtattcattctcgcctt
                                                                                                                 Tech                                                                                                                                                                       

  Sequence-based reagent                       mTMC1-N447C-R                                                     Ruibio\                                                              This paper                                                                                            5':ACAgcctagaagaaga gcaaaaatgcgccccaggag
                                                                                                                 Tech                                                                                                                                                                       

  Sequence-based reagent                       mTMC1-D528C-F                                                     Ruibio\                                                              This paper                                                                                            5':tctcaccgtttctTGTgtcct gaccacttacgtcacgat
                                                                                                                 Tech                                                                                                                                                                       

  Sequence-based reagent                       mTMC1-D528C-R                                                     Ruibio\                                                              This paper                                                                                            5':ACAagaaacggtgagacgc acgaattcctgccccaccattgtttc
                                                                                                                 Tech                                                                                                                                                                       

  Sequence-based reagent                       mTMC1-T532C-F                                                     Ruibio\                                                              This paper                                                                                            5':tgacgtcctgaccTGTta cgtcacgatcctcattggcga
                                                                                                                 Tech                                                                                                                                                                       

  Sequence-based reagent                       mTMC1-T532C-R                                                     Ruibio\                                                              This paper                                                                                            5':ACAggtcaggacgtcaga aacggtgagacgcacgaattc
                                                                                                                 Tech                                                                                                                                                                       

  Sequence-based reagent                       mTMC1-D569C-F                                                     Ruibio\                                                              This paper                                                                                            \
                                                                                                                 Tech                                                                                                                                                                       5':atacacagaattcTGT atcagtggcaacgtcctcgctct

  Sequence-based reagent                       mTMC1-D569C-R                                                     Ruibio\                                                              This paper                                                                                            5':ACAgaattctgtgtatgaag gatatccatattctaagtcccagca
                                                                                                                 Tech                                                                                                                                                                       

  Chemical compound, drug                      Dihydrostreptomycin sulfate                                       HarveyBio                                                                                                                                                                  Cat: HZB1169-1

  Chemical compound, drug                      d-Tubocurarine                                                    TCI                                                                                                                                                                        Cat: C0433

  Chemical compound, drug                      Amiloride                                                         Cayman                                                                                                                                                                     Cat: 21069

  Chemical compound, drug                      MTSET                                                             Cayman                                                                                                                                                                     Cat: 21069

  Chemical compound, drug                      GdCl~3~                                                           Sigma                                                                                                                                                                      Cat: 439770--5G

  Chemical compound, drug                      LaCl~3~                                                           Sigma                                                                                                                                                                      Cat: 298182--10G

  Chemical compound, drug                      CoCl~2~                                                           Sigma                                                                                                                                                                      Cat: 60818--50G

  Chemical compound, drug                      ZnCl~2~                                                           Sigma                                                                                                                                                                      Cat: 793523--100G

  Chemical compound, drug                      MgCl~2~                                                           Sigma                                                                                                                                                                      Cat: M8266-100G

  Chemical\                                    CaCl~2~                                                           Sigma                                                                                                                                                                      Cat: 746495--100G
  compound, drug                                                                                                                                                                                                                                                                            

  Chemical compound, drug                      CsCl                                                              Sigma                                                                                                                                                                      Cat:C3139-25G

  Chemical compound, drug                      KCl                                                               Sigma                                                                                                                                                                      Cat:P9333-500G

  Chemical compound, drug                      NaCl                                                              Sigma                                                                                                                                                                      Cat:S7653-1KG

  Chemical compound, drug                      NaOH                                                              Sigma                                                                                                                                                                      Cat:S8045-500G

  Chemical compound, drug                      KOH                                                               Sigma                                                                                                                                                                      Cat:306568--100G

  Chemical compound, drug                      CsOH                                                              Sigma                                                                                                                                                                      Cat:C8518-10G

  Chemical compound, drug                      BAPTA Tetrasodium salt hydrate                                    Bioruler                                                                                                                                                                   Cat: RH100017-1g

  Chemical compound, drug                      EGTA                                                              Sigma                                                                                                                                                                      Cat: 03780

  Software, algorithm                          Igor 6                                                            WaveMetrics, Inc                                                                                                                                                           

  Software, algorithm                          Micro-manager 1.4                                                 micro-manager.org                                                                                                                                                          

  Software, algorithm                          HEKA patchmaster                                                  HEKA                                                                                                                                                                       

  Software, algorithm                          Matlab 2014                                                       MathWorks                                                                                                                                                                  

  Software, algorithm                          Prism GraphPad 6                                                  GraphPad Software.                                                                                                                                                         

  Other                                        HEKA whole cell recording amplifier                               HEKA                                                                                                                                                                       Order Number: 895273

  Other                                        Micromanipulator                                                  Sensapex                                                                                                                                                                   Cat:uMp-3
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Mouse strains and animal care {#s4-1}
-----------------------------

The mouse strains used in this study, B6.129-TMC1 \< tm1.1Ajg\>/J, B6.129-TMC2 \< tm1.1Ajg\>/J, and B6.129-Lhfpl5 \< tm1Kjn\>/Kjn, were from the Jackson Laboratory (Bar Harbor, ME). The experimental procedures on mice (Animal Protocol \#: 15-XW1) were approved by the Institutional Animal Care and Use Committee of Tsinghua University.

DNA constructs, cochlear culture, and injectoporation {#s4-2}
-----------------------------------------------------

Mouse *Tmc1* and *Tmc2* cDNAs were cloned into CMV-Script and pCDNA3.1- vectors, respectively. To obtain the *Tmc1*-deafness vector and amino-acid-substituted *Tmc1* constructs, specific primers were designed and used for PCR ([Supplementary File 1](#supp1){ref-type="supplementary-material"}). Cochlear culture and injectoporation were performed as previously described ([@bib40]). In brief, the organ of Corti was isolated from P3 mice and cut into three pieces in Dulbecco's modified Eagle's medium/F12 with 1.5 μg/ml ampicillin. For electroporation, a glass pipette (2 μm tip diameter) was used to deliver cDNA plasmids (0.2 μg/μl in 1 × Hanks\' balanced salt solution) to hair cells in the sensory epithelium. EGFP was used as an indicator for the selection of transfected hair cells. A series of three pulses at 60 V lasting 15 ms at 1 s intervals was applied to cochlear tissues by an electroporator (ECM Gemini X2, BTX, CA). The cochlear tissues were cultured for 1 day in vitro and then used for electrophysiological recording.

Electrophysiology {#s4-3}
-----------------

Hair cells were recorded using whole-cell voltage or current clamp as previously described ([@bib39]). All experiments were performed at room temperature (20--25°C). Briefly, the basilar membrane with hair cells was acutely dissected from neonatal mice. The dissection solution contained (in mM): 141.7 NaCl, 5.36 KCl, 0.1 CaCl~2~, 1 MgCl~2~, 0.5 MgSO~4~, 3.4 L-glutamine, 10 glucose, and 10 H-HEPES (pH 7.4). Then the basilar membrane was transferred into a recording chamber with recording solution containing (in mM): 144 NaCl, 0.7 NaH~2~PO~4~, 5.8 KCl, 1.3 CaCl~2~, 0.9 MgCl~2~, 5.6 glucose, and 10 H-HEPES (pH 7.4). For I~Leak~ calculation, the cells were further bathed in recording solution containing 144 mM NMDG that replaced 144 mM NaCl. The acutely isolated or cultured basilar membrane was used for electrophysiological recording within 1 h. Hair cells were imaged under an upright microscope (BX51WI, Olympus, Tokyo, Japan) with a 60 × water immersion objective and an sCMOS camera (ORCA Flash4.0, Hamamatsu, Hamamatsu City, Japan) controlled by MicroManager 1.6 software ([@bib14]). Patch pipettes were made from borosilicate glass capillaries (BF150-117-10, Sutter Instrument Co., Novato, CA) with a pipette puller (P-2000, Sutter) and polished on a microforge (MF-830, Narishige, Tokyo, Japan) to resistances of 4--6 M\'Ω. Intracellular solution contained (in mM): 140 CsCl, 1 MgCl~2~, 0.1 EGTA, 2 Mg-ATP, 0.3 Na-GTP, and 10 H-HEPES, pH 7.2), except when CsCl was replaced with KCl in current-clamp. Hair cells were recorded with a patch-clamp amplifier (EPC 10 USB and Patchmaster software, HEKA Elektronik, Lambrecht/Pfalz, Germany). As measured, the liquid junction potential of the pipette with CsCl intracellular solution had a value of +4 mV in regular recording solution and −6 mV in 144 mM NMDG^+^ solution, which was not corrected in the data shown.

For single-channel recordings, we followed published procedures ([@bib32]; [@bib39]). The intracellular solution was the same for macroscopic and microscopic current recording. To break tip-links, hair bundles were exposed to Ca^2+^-free solution using a fluid jet (in mM): 144 NaCl, 0.7 NaH~2~PO~4~, 5.8 KCl, 5 EGTA, 0.9 MgCl~2~, 5.6 glucose, and 10 H-HEPES, pH 7.4. After bundle destruction, fresh external solution was given to re-establish the corresponding extracellular ionic environment. Two external solutions were used: 3 mM Ca^2+^ solution containing (in mM) 144 NaCl, 0.7 NaH~2~PO~4~, 5.8 KCl, 3 CaCl~2~, 0.9 MgCl~2~, 5.6 glucose, and 10 H-HEPES, pH 7.4; and 35 mM Ca^2+^ solution containing (in mM) 80 NaCl, 0.7 NaH~2~PO~4~, 5.8 KCl, 35 CaCl~2~, 0.9 MgCl~2~, 5.6 glucose, and 10 H-HEPES, pH 7.4. Only traces with obvious single-channel events were included for analyzing.

The sampling rate was 1 kHz for leak current recording, 50 kHz for the IV protocol and current-clamp recording, and 100 kHz for unitary channel recording. The voltage-clamp used a --70 mV holding potential, and the current-clamp was held at 0 pA. Only recordings with a current baseline \<20 pA in NMDG solution were used for statistical analysis.

Hair bundle stimulation and removal {#s4-4}
-----------------------------------

The hair bundle was deflected by two types of mechanical stimulus, fluid jet and glass probe. The fluid jet stimulation was performed as described previously ([@bib5]). In brief, a 40 Hz sinusoidal wave stimulus was delivered by a 27-mm-diameter piezoelectric disc driven by a home-made piezo amplifier pipette with a tip diameter of 3--5 μm positioned 5--10 μm from the hair bundle to evoke maximum MET currents. For glass probe stimulation, hair bundles were deflected with a glass pipette mounted on a P-885 piezoelectric stack actuator (Physik Instrumente, Karlsruhe, Germany). The actuator was driven with voltage steps that were low-pass filtered at 10 KHz. To avoid bundle damage caused by overstimulation, the glass probe was shaped to have a slightly smaller diameter than the hair bundles, and the stimulation distance was 800 nm for macroscopic current and 100 nm for unitary channel recording. For hair bundle removal, a pipette with 1 μm diameter tip was used to suck away the hair bundles of the target OHCs. The hair-bundle-removed OHCs with good condition were further recorded. Examined by a fluid-jet stimulation, the OHCs without obvious MET current were further measured for the leak current.

Inhibitors, ion substitution, permeability, and perfusion {#s4-5}
---------------------------------------------------------

In [Figure 5](#fig5){ref-type="fig"}, DHS, dTC, amiloride, GdCl~3~, and LaCl~3~ were added as calculated to the recording solution (in mM) 144 NaCl, 0.7 NaH~2~PO~4~, 5.8 KCl, 1.3 CaCl~2~, 0.9 MgCl~2~, 5.6 glucose, and 10 H-HEPES (pH 7.4). Dose-inhibition curves were fitted with a Hill equation:$$I_{x}/I_{max} = X^{h}/(K^{h} + X^{h}))$$

Where *K* is the half-inhibition dose (IC50) and *h* is the Hill slope. *I~max~* is the maximal current in control condition.

In [Figure 6](#fig6){ref-type="fig"}, all the ion substitution solutions were derived from a simplified external solution (in mM): 147 NaCl, 1.3 CaCl~2~, 5.6 glucose, and 10 H-HEPES (pH 7.4). In [Figure 6A](#fig6){ref-type="fig"}, LiCl and CsCl were 150 mM, completely substituting for NaCl. In [Figure 6B](#fig6){ref-type="fig"}, the Ba^2+^ solution was (in mM) 10 BaCl~2~, 137 NaCl, 1.3 CaCl~2~, 5.6 glucose, and 10 H-HEPES (pH 7.4); the Zn^2+^ solution was 75 ZnCl~2~, 75 NaCl, 1.3 CaCl~2~, 5.6 glucose, and 10 H-HEPES (pH 7.4); the Co^2+^ solution was 75CoCl~2~, 75 NaCl, 1.3 CaCl~2~, 5.6 glucose, and 10 H-HEPES (pH 7.4); the Mg^2+^ solution was 150 MgCl~2~, 5.6 glucose, and 10 H-HEPES (pH 7.4); and the Ca^2+^ solution was 75 CaCl~2~, 75 NaCl, 5.6 glucose, and 10 H-HEPES (pH 7.4).

Ca^2+^ permeability was measured by performing whole-cell voltage-clamp recording on P6 OHCs, with intracellular solution containing (in mM): 140 CsCl, 1 MgCl~2~, 0.1 EGTA, 2 Mg-ATP, 0.3 Na-GTP, and 10 H-HEPES, pH 7.2. A voltage-ramp stimulation from −120 to 80 mV lasting for 2 s was applied to calculate the reversal potential. For measuring Na^+^ permeability, OHCs were perfused with the external solution containing (in mM): 150 NaCl,1.3 CaCl~2~, 5.6 glucose, and 10 H-HEPES. For measurement of Ca^2+^ or Mg^2+^ permeability, 150 NaCl was substituted with 75 Ca^2+^ or 75 Mg^2+^ supplemented with 75 NMDG^+^. To eliminate the influence of technical leak, an identical voltage-ramp stimulation was applied on each recorded OHC in 150 NMDG. The part of the inward current trace was fitted linearly to calculate the voltage value cross point between interest of ion and NMDG solution, which represented the reverse potential of the leak between this ion and Cs^+^. The relative permeability of the monovalent cation was calculated as described ([@bib20])$$P_{X}/P_{Cs} = \lbrack Cs\rbrack_{i}exp(Er_{rev}F/RT)/\lbrack X\rbrack_{o}$$

And for divalent cations, the equation was:$$P_{X}/P_{Cs} = \gamma_{Cs}\lbrack Cs\rbrack_{i}exp(Er_{rev}F/RT)\lbrack exp(E_{rev}/RT) + 1\rbrack/4\gamma_{X}\lbrack X\rbrack_{o}$$

For which γ~Cs~ = 0.70 ([@bib20]), γ~Ca~ = 0.4657, γ~Mg~ = 0.5271 ([@bib33]).

*E~rev~* means reversal potential, *F* and *R* mean Faraday constant and gas constant, *T* means absolute temperature. For calculation, 25°C was used as the value for room temperature.

For the Ca-NMDG solution in [Figure 6E-F](#fig6){ref-type="fig"}, 1 CaCl~2~ was exchanged for 2 NMDG-Cl. For the Na-Ca solution in [Figure 6G](#fig6){ref-type="fig"}, 2 NaCl was exchanged for 1 CaCl~2~. The osmotic pressure of each solution was re-adjusted to 300--320 mOsm/kg with sucrose, and the pH was adjusted to 7.4.

The gravity perfusion system (ALA-VM8, ALA Scientific Instruments, Farmingdale, NY) is controlled manually to switch and deliver solutions. The perfusion tubing and tip were modified as previously reported ([@bib37]). For cochlear tissue, the perfusion tip was placed 2--3 mm from the patched hair cell and the perfusion rate was \~0.5 ml/min. Extra solution in the recording dish was removed by a peristaltic pump (PeriStar, World Precision Instruments, Sarasota, FL) to maintain a steady liquid level.

Data analysis {#s4-6}
-------------

Every experiment contained at least three biological replicates, which were collected at least every 2 weeks within a 3 month window to maintain the stability of a data set. For certain experiments, such as single-channel recording, the trace numbers were over 100. All cell numbers were noted in the figure legends. Multiple recordings from one cell with the identical stimulus protocol were considered as technical replications, which were averaged to generate a single biological replication representing value/data from one cell. Data were managed and analyzed with Excel (Microsoft), Prism 6 (GraphPad Software, San Diego, CA), and Igor pro 6 (WaveMetrics, Lake Oswego, OR). The current traces similar to [Figure 1B](#fig1){ref-type="fig"} were low-pass filtered to less noisy traces with the smoothing function (Binomial 20) provided by Igor software. All data are shown as mean ± SEM. We used student's T-test for one-to-one comparison and ANOVA for multiple comparisons to determine statistical significance (\*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001). Values and N numbers are defined in the figures and figure legends.
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###### Primers used for generating desired truncation and mutations in mouse *Tmc1* cDNA.

Specific primers were designed for PCR of the *Tmc1*-deafness vector and amino-acid-substituted *Tmc1* constructs, based on the pCDNA3.1 vector containing mouse *Tmc1* cDNA. DF, deafness; F, forward; R, reverse.

10.7554/eLife.47441.028

Data availability {#s7}
=================

All data generated or analysed during this study are included in the manuscript and supporting files.

10.7554/eLife.47441.030

Decision letter

Bergles

Dwight E

Reviewing Editor

Johns Hopkins University School of Medicine

United States

Barr-Gillespie

Peter G

Reviewer

Oregon Health and Science University

United States

Ricci

Anthony J

Reviewer

Stanford University

United States

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"TMC1 confers a leak conductance to modulate excitability of auditory hair cells in mammals\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Richard Aldrich as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Peter G Barr-Gillespie (Reviewer \#2); Anthony J Ricci (Reviewer \#3).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

This is an interesting study which examined the contribution of TMC1 to the resting membrane \"leak\" conductance of hair cells in the mammalian cochlea. An understanding of the proteins involved in forming MET channels and other sources of resting membrane current in hair cells is lacking and continues to be an issue of great controversy. The authors approach this question by performing whole cell voltage clamp recordings from OHCs and IHCs in cochlea isolated from pre-hearing mice, in combination with pharmacological and genetic manipulations. The experiments provide evidence that TMC1 can contribute to a resting \"leak\" conductance that is in many ways distinct from the MET. Most striking is the lack of MTSET effects on TMC1 cysteine mutants thought to reside within the pore; in particular, MTSET does not alter the leak but reduces the transduction current in Tmc1 ko OHCs expressing TMC1-M412C. This is a remarkable finding and it is hard to understand how this could occur if these amino acids are part of a pore formed by TMC1. The experiments have been conducted carefully and the inclusion of long duration recording traces are particularly impactful and illustrate the consequences of the manipulations particularly clearly. There are however multiple issues with the work that need clarification before publication. The majority of the comments are related to presentation and interpretation, which make it difficult to appreciate the overall significance of the findings, given that the majority of the experiments focus on excitability of OHCs.

Essential revisions:

1\) The writing and grammar in the manuscript needs a complete overhaul. There are many mistakes and unclear wordings which interfere with understanding what the authors are trying to convey.

2\) Figure 1 panel B, what do the light gray and pink traces represent? (This is in most of the figures and should be stated at least in the first legend). I~m~ and I~BG~ should be defined directly, particularly in the legend. It is unclear the point of Figure 1G, but it should include an estimate of the reversal potential for each conductance. Do you know that the permeation of NMDG is the same or different between conductances?

3\) The authors should provide better justification that either the endogenous or overexpressed leak is coming from the hair bundle. Might these channels be on the soma?

4\) The mutagenesis data suggest TMC1 is part of the leak conductance, but the authors should not overstate the evidence to indicate that it is the channel. It might be a component and that can be suggested, but until the protein can be shown to actually be a channel, a more conservative approach to the writing would make sense. Basing conclusions on work that, in itself is not yet complete, weakens the argument. Given that the subunit composition and pore structure of the native channels will impact how the cysteine mutations manifest, these data should be used to highlight that the two conductances can be separated rather than used as evidence that it is the channel.

5\) Descriptions of resting membrane current are only relevant when discussing what membrane potential the hair cells were held at. The recording configuration should also be described as whole-cell voltage clamp, not \"patch-clamp\" as patches of membrane were not isolated for these experiments.

6\) It is not clear why the authors make the statement that \"the inward I~BG~ was dramatically reduced in Tmc1-knockout OHCs\", as both inward and outward components are reduced to nearly similar degrees in Tmc1-ko OHCs.

7\) Statements about current amplitudes should include the data (average + SD/SEM and N values). The authors report current amplitudes significant to two decimal places, that is to the level of femtoamperes -- this seems unnecessary, given the noise level of the recordings (5-10 pA, Figure 1B). Here and elsewhere-four significant digits makes no sense (unless the measurement is so precise that the errors justify it). Please report the error (SD or SEM, with n), keep the error to two significant digits, and adjust the significant digits in the mean accordingly.

8\) Statistical analysis -- the authors exclusively perform Student\'s T-tests, which it would be more appropriate to perform ANOVA followed by post-hoc test, to assess multiple comparisons (e.g. Figure 2D, Figure 6B, etc).

9\) Why was the current amplitude so much smaller for the P3+ 1 OHCs than the acute P6 OHCs? It is notable that the resting current measured at P3 +1 is not different from the P6 TMC ko OHCs. Could the transfection be affecting the health of the cells?

10\) \"These data indicated that hair cells possess a background leak conductance, conferred specifically by TMC1.\" Given the complexity (and controversy) surrounding conductances in hair cells, I feel that this statement is too strong. It certainly suggests that TMC1 is necessary for the leak, but does not show it mediates it directly. In this regard, the lack of MTSET sensitivity could be regarded as refuting this hypothesis.

11\) \"Exogenously expressed TMC2 was significantly located in hair bundle of OHCs, as shown by HA tag (Figure 2---figure supplement 1).\" I don\'t find this statement compelling based on the fluorescent traces provided. Images with better optical sectioning should be provided. The use of the word \"significantly\" should be backed by a quantitative assessment.

12\) \"Thus, neither mechanical nor pharmacological blockade of the MET channel affect I~Leak~ \" This statement is also too strong. What the experiments show is that there is a holding current that persists when MET channels are closed or blocked with DHS. The experiments do not directly assess whether the leak current is affected by these manipulations.

13\) Most striking is the MTSET effect -- it does not alter the leak but reduces the transduction current in Tmc1 ko OHCs expressing TMC1-M412C. However, the high variability in I~Leak~ measurements decrease the power of the conclusions regarding the ability of different cysteine mutations to restore the leak current (particularly for M412C, T532C). What accounts for the high variance in this measurement? It is surprising that 5 out of the 6 cysteine mutants failed to restore the leak current. It is hard to reconcile that result with the idea that TMC1 contributes its pore both to the MET conductance and to the leak conductance. It is equally strange that M412C behaved identically to WT. Further discussion/clarification on these points is necessary.

14\) Panel C in Figure 4---figure supplement 1 is not explained in the figure legend and there are no n values for these experiments.

15\) To assess excitability, the authors move to IHCs, but there is insufficient evidence of TMC1 dependent leak current with similar characteristics in IHCs. The authors should indicate what age and location (along the cochlea) was used for these recordings.

16\) The discussion of excitability changes was difficult to follow. In particular, the statements \"the V~m~ was largely hyperpolarized\" should be supported by data for clarity and the statement \"Although the V~m~ in the non-bursting state was more hyperpolarized than in the bursting state in wild-type IHCs, it was positive to the V~m~ in Tmc1-knockout IHCs (Figure 7A,B).\" needs to be revised.

17\) The change in firing behavior TMC1 ko IHCs is difficult to understand. Presumably, these cells have a higher membrane resistance, so all other things being equal, they should experience greater depolarization for a given current injection, therefore increasing their excitability. As described, this is opposite to the phenotype observed. To control for resting state changes, these experiments should be repeated by measuring input output at the same membrane potential (neglecting the amount of current required to hold the cells at the same potential).

18\) The authors make the statement \"The MET current decreased from apex to base in Tmc1-knockout OHCs, which might result from that the hair bundle got more disrupted at base coil.\" If there could be differences in MET current amplitudes due to damage, this needs to be explored more thoroughly and accounted for, as it could complicate interpretation of the current amplitude gradients.

19\) The variation in Ca sensitivity between MET and leak currents (Figure 8) is very perplexing and the authors do not provide a compelling answer to the observed variation.

20\) The authors discuss three measured or derived currents: I-membrane, I-background, and I-leak. The writing and figures make it very difficult to figure out exactly what they are referring to, especially the difference between I-background and I-leak. I figured it out, but it took work. The distinction between these currents needs to be made much more clear.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled \"TMC1 Is an Essential Component of a Leak Channel Underlying Tonotopy and Excitability of Auditory Hair Cells in Mice\" for further consideration at *eLife*. Your revised article has been favorably evaluated by Richard Aldrich (Senior Editor), a Reviewing Editor, and two reviewers.

The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below:

1\) The general writing of the manuscript is still an obstacle to understanding the work. It needs major grammatical check as well as structural work to increase clarity and interpretation. For the revision, please send a version of the file with changes incorporated (without the Word edits highlighted). It is difficult to read the manuscript in this format.

2\) The description of the contribution of TMC1 to the MET and leak currents needs further revision. For example, in the Discussion section: \"Hence, we suggest a working model in which TMC1 integrates with the MET channel and a leak channel, and tunes the activity of hair cells.\" the authors should be more explicit about their thinking-it\'s not that TMC1 can be a leak channel or a MET channel, but it can incorporate into each. That makes interpretation of the results-especially the striking differences in behavior of the mutants-more understandable. This is an important point as some may have been thinking that the transduction channel (and the leak channel, by parallel) is just the TMCs, but it must be more complicated.

3\) Subsection "The leak current modulates action potential firing in IHCs". For the Tmc1 KO effects on excitability, how do we distinguish a reduction of MET resting Popen from the reduction in the leak current?

4\) Subsection "TMC1 but not TMC2 mediates a background current in hair cells". Change \"the I~m~ was little (Figure 1B)...\" to \"the I~m~ was small (Figure 1B),...\" (changing the word and adding a comma).

5\) Subsection "TMC1 but not TMC2 mediates a background current in hair cells". Change to \"falls after P4\".

6\) Subsection "TMC1-mediated leak current is not carried by the resting open MET channel". Change to something like: \"Due to existing tension in the hair bundle, the open probability of MET channels at rest in hair cells is significant...\"

7\) Throughout. Unless it is used as a compound adjective, \"amino-acid\" or \"amino-acids\" should be changed to \"amino acid\" and \"amino acids.\"

8\) Subsection "Amino-acid substitutions in TMC1 alter the TMC1-mediated leak current". The clause \"neglecting to express any of the six cysteine-substituted TMC1 constructs\" doesn\'t make sense.

9\) Subsection "The leak current modulates action potential firing in IHCs". The usual vernacular is to \"depolarize the membrane,\" rather than \"depolarize the membrane potential.\"

10\) I\'m not 100% sure, but I didn\'t think worm TMC-1 and TMC-2 are specifically homologous to (respectively) TMC1 and TMC2.

11\) Discussion section. I don\'t understand this sentence: \"However, it is still not yet explained that only a quarter proportion of TMC1 proteins are localized at the MET site, whereby counting around 2 MET complexes exist...\"

12\) The interpretation of the IV curves needs to be clarified. I would assume that the IV curves represent complex currents, not just leak and MET but other voltage gated channels as well. Would further assume the outward currents are not affected by NMDG but rather by the internal ions. So how these plots are interpreted is important and might be different depending on the voltage range that is investigated.

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled \"TMC1 Is an Essential Component of a Leak Channel Underlying Tonotopy and Excitability of Auditory Hair Cells in Mice\" for further consideration by *eLife*. Your revised article has been evaluated by Richard Aldrich (Senior Editor) and a Reviewing Editor.

The manuscript has been improved but there are some minor revisions that are necessary for clarity, as outlined below:

Title:

TMC1 Is an Essential Component 1 of a Leak Channel Underlying Tonotopy and Excitability of Auditory Hair Cells in Mice

Change \"underlying\" to \"that modulates\".

Abstract:

Change to \"The leak conductance is graded in frequency-dependent manner along the length of the cochlea...\".

our results showed -- change to \"show\".

Introduction:

\"it is a pore-forming subunit\" -- define what \"it\" is.

Results:

It is noteworthy to point out that, I~BG~ was used as the title of vertical axis to show the dosage effect (Figure 5), but it represented the leak component when the concentration of blockers was high enough.

Revise -- it is not clear which leak component you are referring to:

A significant leak conductance would be expected in order to depolarize the membrane and affect cell excitability,

Revise -- \"would be expected to depolarize...\",

10.7554/eLife.47441.031

Author response

> Summary:
>
> This is an interesting study which examined the contribution of TMC1 to the resting membrane \"leak\" conductance of hair cells in the mammalian cochlea. \[...\] The majority of the comments are related to presentation and interpretation, which make it difficult to appreciate the overall significance of the findings, given that the majority of the experiments focus on excitability of OHCs.

Thank you for the constructive comments and suggestions that helped us to greatly improve the manuscript. We have conducted the requested experiments and integrated them in the revised manuscript.

> Essential revisions:
>
> 1\) The writing and grammar in the manuscript needs a complete overhaul. There are many mistakes and unclear wordings which interfere with understanding what the authors are trying to convey.

We have sent the manuscript to a professional English editor for a review of the overall writing and grammar.

> 2\) Figure 1 panel B, what do the light gray and pink traces represent? (This is in most of the figures and should be stated at least in the first legend). I~m~ and I~BG~ should be defined directly, particularly in the legend. It is unclear the point of Figure 1G, but it should include an estimate of the reversal potential for each conductance. Do you know that the permeation of NMDG is the same or different between conductances?

In Figure1B, the light gray and pink traces represent the low-pass filtered curves from original recordings that are noisier, which was done using Igor software and has been stated in Figure 1 legend, as well as in the Materials and methods section in the revised manuscript.

We updated the names of membrane currents to I~m~, I~Na~, I~NMDG~, and I~BG.~ They are defined in the text and Figure 1 legend. "For more accurate quantification, the amplitude of the background current (I~BG~) was calculated by subtracting the I~m~ in 144 NMDG solution (I~NMDG~) from that in Na^+^ solution (I~Na~)", which can be found in subsection" TMC1 but not TMC2 mediates a background current in hair cells "and Figure 1 legend.

Our intention was to show the voltage dependence of I~BG~ in the original Figure 1G (new Figure 1I). The I-V traces were recorded before and after 144 NMDG treatment extracellularly to make this measurement. Hence, only inward I~BG~ was calculated. In the revised version, an estimated reversal potential for I~BG~ from wild-type and TMC1-KO mice has been shown in new Figure 1H.

In terms of NMDG permeation, we made a comparison in the new Figure 1D. It appears that, *Tmc1*-KO has less NMDG current, but it is difficult to determine whether it is the technical leak from the whole-cell recordings, or the NMDG-permeable current.

> 3\) The authors should provide better justification that either the endogenous or overexpressed leak is coming from the hair bundle. Might these channels be on the soma?

To answer this question, we designed an experiment by whole-cell recording OHCs after removing their hair bundles. We hypothesized that, if the leak current reduced in major proportion, the leak is coming from the hair bundle. If not, then the leak is coming from the soma. Our result showed that, the leak current decreased to 10 pA in hair-bundle removed OHCs, compared to the 48 pA leak current from intact OHCs. This piece of evidence indicated that, the leak conductance likely comes from the hair bundle. We did not successfully achieve similar recordings in cultured and overexpressed OHCs. We thought this figure helped to strengthen the conclusion of the manuscript. Hence, it was embedded in the revised manuscript as Figure 3---figure supplement 1.

> 4\) The mutagenesis data suggest TMC1 is part of the leak conductance, but the authors should not overstate the evidence to indicate that it is the channel. It might be a component and that can be suggested, but until the protein can be shown to actually be a channel, a more conservative approach to the writing would make sense. Basing conclusions on work that, in itself is not yet complete, weakens the argument. Given that the subunit composition and pore structure of the native channels will impact how the cysteine mutations manifest, these data should be used to highlight that the two conductances can be separated rather than used as evidence that it is the channel.

We have removed the statement from the manuscript to indicate that TMC1 is the channel for leak conductance. In the revised version, we explain that, the channel is an essential component for the leak channels. Accordingly, we focused on our discussion regarding that, the properties and function of the leak channel are distinct to that of the MET channel.

> 5\) Descriptions of resting membrane current are only relevant when discussing what membrane potential the hair cells were held at. The recording configuration should also be described as whole-cell voltage clamp, not \"patch-clamp\" as patches of membrane were not isolated for these experiments.

We have changed the wording "whole-cell patch-clamp" to "whole-cell voltage-clamp" or "whole-cell current-clamp" based on the configuration used in each experiment.

> 6\) It is not clear why the authors make the statement that \"the inward I~BG~ was dramatically reduced in Tmc1-knockout OHCs\", as both inward and outward components are reduced to nearly similar degrees in Tmc1-ko OHCs.

In the second part of Figure 1, we intended to measure the voltage dependence of I~BG~ based on I-V protocol. The original Figure 1E (new Figure 1F) only showed the traces before NMDG treatment. Currently, the I-V traces before and after NMDG treatment were shown in new Figure 1F. The I~BG~ was measured from membrane currents before and after NMDG treatment extracellularly. Hence, only inward current (new Figure 1I / original Figure 1G) was measured from the I-V recordings in new Figure 1F (original Figure 1E). We also changed the sentence to "After subtraction, it was clear that the I~BG~ altered with holding potentials and was dramatically reduced in *Tmc1*-knockout OHCs (Figure 1I)". Now in subsection "TMC1 but not TMC2 mediates a background current in hair cells".

> 7\) Statements about current amplitudes should include the data (average + SD/SEM and N values). The authors report current amplitudes significant to two decimal places, that is to the level of femtoamperes -- this seems unnecessary, given the noise level of the recordings (5-10 pA, Figure 1B). Here and elsewhere-four significant digits makes no sense (unless the measurement is so precise that the errors justify it). Please report the error (SD or SEM, with n), keep the error to two significant digits, and adjust the significant digits in the mean accordingly.

In the revised version, we described mean+/-SD/SEM, n values and applied statistical analysis in every figure legend. For example, in Figure 1 it says, "Data are presented as mean ± SEM. N values are shown in each panel. \*p \<0.05, \*\*p \<0.01, \*\*\*p \<0.001, Student's t-test". We have changed all the current value to integers and made according adjustment to the values from other measurements (e.g. V~m~ in Figure 7).

> 8\) Statistical analysis -- the authors exclusively perform Student\'s T-tests, which it would be more appropriate to perform ANOVA followed by post-hoc test, to assess multiple comparisons (e.g. Figure 2D, Figure 6B, etc.).

In the revised manuscript, we applied statistical analysis based on the characteristics of the data set. For example, for one-to-one comparison we used student's T-test, and for multiple comparisons we used ANOVA.

> 9\) Why was the current amplitude so much smaller for the P3+ 1 OHCs than the acute P6 OHCs? It is notable that the resting current measured at P3 +1 is not different from the P6 TMC ko OHCs. Could the transfection be affecting the health of the cells?

We added experiments demonstrating that, P6 OHCs was cultured for 1 day in vitro (P6+1DIV) and whole-cell voltage-clamp was recorded. The leak current amplitude was approximately 64 pA ([Author response image 1](#respfig1){ref-type="fig"}, left bar), relevant to that (71 pA) recorded from P6 OHCs in acutely dissociated cochlea tissue ([Author response image 1](#respfig1){ref-type="fig"}, right bar, adapted from Figure 1E). Similarly, Figure 2 showed that leak current was 18 pA in P3+1DIV OHCs (Figure 2D) and the leak current was 19 pA in dissociated P3 OHCs (Figure 2F). From these data, 1-DIV culture did not obviously affect the leak function of the OHCs.

![](elife-47441-resp-fig1){#respfig1}

> 10\) \"These data indicated that hair cells possess a background leak conductance, conferred specifically by TMC1.\" Given the complexity (and controversy) surrounding conductances in hair cells, I feel that this statement is too strong. It certainly suggests that TMC1 is necessary for the leak, but does not show it mediates it directly. In this regard, the lack of MTSET sensitivity could be regarded as refuting this hypothesis.

We have changed the statement to, "These data indicated that, hair cells possess a background leak conductance that functionally couples with TMC1" in subsection "TMC1 but not TMC2 mediates a background current in hair cells". We also made a statement explaining that, TMC1 is essential for the leak current, but the leak channel possesses different properties from the MET channel in terms of the role of TMC1.

> 11\) \"Exogenously expressed TMC2 was significantly located in hair bundle of OHCs, as shown by HA tag (Figure 2---figure supplement 1).\" I don\'t find this statement compelling based on the fluorescent traces provided. Images with better optical sectioning should be provided. The use of the word \"significantly\" should be backed by a quantitative assessment.

We have again performed the immunostaining experiment on TMC2-HA transfected cochleae. This time, imaging with better optical effect was collected, which showed condensed HA staining on hair bundle layer (new Figure 2---figure supplement 1). We also changed the word, "significantly" to "visibly". Subsection "TMC1 but not TMC2 mediates a background current in hair cells".

> 12\) \"Thus, neither mechanical nor pharmacological blockade of the MET channel affect I~Leak~ \" This statement is also too strong. What the experiments show is that there is a holding current that persists when MET channels are closed or blocked with DHS. The experiments do not directly assess whether the leak current is affected by these manipulations.

We changed the sentence to, "the I~Leak~ persisted in either mechanical closure or pharmacological blockade of the MET channel". Subsection "TMC1-mediated leak current is not carried by the resting open MET channel".

> 13\) Most striking is the MTSET effect -- it does not alter the leak but reduces the transduction current in Tmc1 ko OHCs expressing TMC1-M412C. However, the high variability in I~Leak~ measurements decreases the power of the conclusions regarding the ability of different cysteine mutations to restore the leak current (particularly for M412C, T532C). What accounts for the high variance in this measurement? It is surprising that 5 out of the 6 cysteine mutants failed to restore the leak current. It is hard to reconcile that result with the idea that TMC1 contributes its pore both to the MET conductance and to the leak conductance. It is equally strange that M412C behaved identically to WT. Further discussion/clarification on these points is necessary.

In this study, we described that, the leak current that was around 60 pA, less than that from most of general channels. Especially, under treatment or manipulation of hair cells (e.g. tissue culture status and TMC1 overexpression), the current amplitude varies depending on quantity of TMC1 proteins. Our solution was to make more recordings in order to gain better quantification from mean and distribution analysis. Based on amino-acid substitution experiment and other results, the leak channel demonstrated distinct properties from the MET channel, including the M412C that regulated the MET channel conductance but not the leak channel conductance. We agreed that, M412 is an interesting site and that M412C mutation did not affect the leak current, even with MTSET treatment. While previous evidence has shown that MTSET treatment of M412C reduces the MET current (Pan et al., 2018), and M412K causes deafness without affecting the MET current in Beethoven mice (Marcotti et al., 2006). In terms of the leak conductance, M412C behaved similar to wild-type, which is not atypical since other evidence has shown the distinct dosage sensitivities to factors (e.g. channel blockers and calcium, between the leak channel and the MET channel). In the revised manuscript, we stated that, TMC1 is essential for the leak channel, but it not yet ready to claim it as the pore for the leak channel. In the discussion, the difference between leak and MET channels are stated. Discussion section.

> 14\) Panel C in Figure 4---figure supplement 1 is not explained in the figure legend and there are no n values for these experiments.

In the revised manuscript, the Figure 4---figure supplement 1. Panel C has been described in the figure legend and the n values were added

> 15\) To assess excitability, the authors move to IHCs, but there is insufficient evidence of TMC1 dependent leak current with similar characteristics in IHCs. The authors should indicate what age and location (along the cochlea) was used for these recordings.

For the IHC recordings, the mouse age was P6 and the location recorded was 0.4 to the very apex as length of the whole cochlear coil was 1.0. At the same age and recording location of cochlea, the leak current amplitude was obviously different between IHCs (24 pA, n=11, previous Figure 7D) and OHCs (51 pA, n=9, new Figure 3E). We also added more IHC recordings to raise the n value from 11 to 20, with the leak current being 25 pA (new Figure 7D); similar to the previous value. We hypothesized that, it may have resulted from the less number of TMC1 proteins in IHCs compared to that in OHCs (Beurg et al., 2018), which is discussed. Subsection "The leak current modulates action potential firing in IHCs".

> 16\) The discussion of excitability changes was difficult to follow. In particular, the statements \"the V~m~ was largely hyperpolarized\" should be supported by data for clarity and the statement \"Although the V~m~ in the non-bursting state was more hyperpolarized than in the bursting state in wild-type IHCs, it was positive to the V~m~ in Tmc1-knockout IHCs (Figure 7A,B).\" needs to be revised.

The sentence \"the V~m~ was largely hyperpolarized\" was changed to "the resting V~m~ was more hyperpolarized" in subsection "The leak current modulates action potential firing in IHCs". It was supported by the quantification in Figure 7B. The statement \"Although the V~m~ in the non-bursting state was more hyperpolarized than in the bursting state in wild-type IHCs, it was positive to the V~m~ in Tmc1-knockout IHCs (Figure 7A,B).\" was revised to "Although the V~m~ baseline in the non-bursting state was more hyperpolarized than that in the bursting state in wild-type IHCs, it was still more depolarized than the V~m~ baseline in *Tmc1*-knockout IHCs (Figure 7A,B)" subsection "The leak current modulates action potential firing in IHCs".

> 17\) The change in firing behavior TMC1 ko IHCs is difficult to understand. Presumably, these cells have a higher membrane resistance, so all other things being equal, they should experience greater depolarization for a given current injection, therefore increasing their excitability. As described, this is opposite to the phenotype observed. To control for resting state changes, these experiments should be repeated by measuring input output at the same membrane potential (neglecting the amount of current required to hold the cells at the same potential).

We added experiments to answer this question. By adjusting holding current, the membrane potential was brought to -60 mV in wild-type and *Tmc1*-knockout IHCs. When injecting additional 50 pA current, the firing rate of action potentials in *Tmc1*-knockout IHCs was higher than that in wild-type IHCs, as shown in [Author response image 2](#respfig2){ref-type="fig"}. Hence, it is not opposite to the phenotype we described in Figure 7. Due to lack of the leak conductance that induces a higher membrane resistance in Tmc1-knockout IHCs than that in wild-type IHCs, the V~m~ is more hyperpolarized and action potential fires less in resting condition. Hence, when artificially bringing the holding V~m~ to an identical level followed by injecting the same amount of current, the action potential fires more in *Tmc1*-knockout IHCs.
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> 18\) The authors make the statement \"The MET current decreased from apex to base in Tmc1-knockout OHCs, which might result from that the hair bundle got more disrupted at base coil.\" If there could be differences in MET current amplitudes due to damage, this needs to be explored more thoroughly and accounted for, as it could complicate interpretation of the current amplitude gradients.

The numbers of expressed TMC1 proteins could determine the amplitude of the MET current. In the revised manuscript, we stated that, "the leak and MET current decreased from apex to base in *Tmc1*-knockout OHCs, which correlated with the graded expression level of TMC1 along the cochlear coil" in subsection "The leak current follows the tonotopic gradient of the MET response in OHCs". Moreover, we discussed the rationality in the Discussion section.

> 19\) The variation in Ca sensitivity between MET and leak currents (Figure 8) is very perplexing and the authors do not provide a compelling answer to the observed variation.

As shown in Figure 6C,D, the P~Na~/P~Cs~ was 0.7 and the P~Ca~/P~Cs~ was 0, indicating Ca^2+^ barely entered the leak channel. This dataset could not be used to calculate Ca^2+^ permeability of the MET channel because we added DHS in the external solution. Thus, we included an experiment to measure the Ca^2+^ permeability of MET channel. The P~Na~/P~Cs~ is 1.3, while the P~Ca~/P~Cs~ is 6.4, which is consistent with the report by Kim and Fettiplace, (2013). Figure 6F showed a typical dosage-dependent inhibition of Ca^2+^ on the leak conductance but not on MET channel. Thus, in Figure 8D,E, 35 mM Ca^2+^ transiently abolished the leak current and tonotopic gradient of the MET current in wild-type OHCs, similar to Tmc1-deficiency induced effect. In the revised manuscript, we compared the difference between the MET channel and the leak channel in terms of the Ca^2+^ sensitivity in OHCs. We hypothesized that, Ca^2+^ may inhibit the leak channel, although it is permeable to the MET channel.

> 20\) The authors discuss three measured or derived currents: I-membrane, I-background, and I-leak. The writing and figures make it very difficult to figure out exactly what they are referring to, especially the difference between I-background and I-leak. I figured it out, but it took work. The distinction between these currents needs to be made much more clear.

We introduced a series of values for further measurement in the revised manuscript. They are I[~m~]{.ul} (recorded membrane current), I~Na~ (I~m~ under 144 Na recording solution), I~NMDG~ (I~m~ under 144 NMDG treatment), I~BG~ (background current by subtracting I~NMDG~ from I~Na~), I~DHS~ (I~m~ under 100 μM DHS treatment), and I~Leak~ (resting-MET independent leak current). In Figure 1 legend, it says, "I~BG~ (background current) was calculated by subtraction of I~m~ in 144 Na (I~Na~) and I~m~ in 144 NMDG (I~NMDG~) to exclude technical leak". In text, it says, "For more accurate quantification, the amplitude of the background current (I~BG~) was calculated by subtracting the I~m~ in 144 NMDG solution (I~NMDG~) from that in Na^+^ solution (I~Na~)", subsection "TMC1 but not TMC2 mediates a background current in hair cells". In Figure 3 legend, it says, "The baseline current was similar when the MET channels were closed by either FJ (\#1) or DHS (I~DHS~, \#2), as highlighted with a red dashed line. As shown in \#3, the DHS-sensitive resting MET current (I~Resting-MET~) was calculated by subtraction of I~Na~ and I~DHS~. The baseline current was further closed by NMDG, defined as I~Leak~ by subtraction of I~DHS~ and I~NMDG~.".

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

> The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below:
>
> 1\) The general writing of the manuscript is still an obstacle to understanding the work. It needs major grammatical check as well as structural work to increase clarity and interpretation. For the revision, please send a version of the file with changes incorporated (without the Word edits highlighted). It is difficult to read the manuscript in this format.

We have gone through a major grammatical check and made some structural work to improve the clarity and interpretation.

> 2\) The description of the contribution of TMC1 to the MET and leak currents needs further revision. For example, in the Discussion section: \"Hence, we suggest a working model in which TMC1 integrates with the MET channel and a leak channel, and tunes the activity of hair cells.\" the authors should be more explicit about their thinking-it\'s not that TMC1 can be a leak channel or a MET channel, but it can incorporate into each. That makes interpretation of the results-especially the striking differences in behavior of the mutants-more understandable. This is an important point as some may have been thinking that the transduction channel (and the leak channel, by parallel) is just the TMCs, but it must be more complicated.

We have updated the last paragraph to clarity our opinion in the Discussion section. For example, "Hence, we suggest a working model in which TMC1 functionally incorporates into a leak channel and the MET channel, rather than being the pore of the two channels, and tunes the activity of hair cells."

> 3\) Subsection "The leak current modulates action potential firing in IHCs". For the Tmc1 KO effects on excitability, how do we distinguish a reduction of MET resting Popen from the reduction in the leak current?

In Figure 7, the IHCs were recorded in the external solution with 100 μM dihydrostreptomycin that was used to block the resting and/or evoked MET currents. We changed the sentence in subsection "The leak current modulates action potential firing in IHCs" to "Therefore, we measured the membrane potential (V~m~) bathed in IHCs in external solution with 100 μM DHS by whole-cell current-clamp recording (Figure 7A)." and the sentences to "(A) Representative current-clamp recording in IHCs bathed in external solution with 100 μM DHS from wild-type (black) and Tmc1-knockout (red) mice." on line 484 and "In this figure, the external solution contained 1.3 mM Ca^2+^ and 100 μM DHS in figure legend accordingly.

> 4\) Subsection "TMC1 but not TMC2 mediates a background current in hair cells". Change \"the I~m~ was little (Figure 1B)...\" to \"the I~m~ was small (Figure 1B),...\" (changing the word and adding a comma).

It has been changed to "the I~m~ was small (Figure 1B),".

> 5\) Subsection "TMC1 but not TMC2 mediates a background current in hair cells". Change to \"falls after P4\".

It has been changed to "falls after P4".

> 6\) Subsection "TMC1-mediated leak current is not carried by the resting open MET channel". Change to something like: \"Due to existing tension in the hair bundle, the open probability of MET channels at rest in hair cells is significant...\"

It has been changed.

> 7\) Throughout. Unless it is used as a compound adjective, \"amino-acid\" or \"amino-acids\" should be changed to \"amino acid\" and \"amino acids.\"

In the text, most of expression "amino-acid" has been changed to "amino acid", excepting in several place "amino-acid" has been used as a compound adjective.

> 8\) Subsection "Amino-acid substitutions in TMC1 alter the TMC1-mediated leak current". The clause \"neglecting to express any of the six cysteine-substituted TMC1 constructs\" doesn\'t make sense.

We change the sentence to "did not, however, change the current baseline in OHCs when expressing any of the six cysteine-substituted TMC1 constructs".

> 9\) Subsection "The leak current modulates action potential firing in IHCs". The usual vernacular is to \"depolarize the membrane,\" rather than \"depolarize the membrane potential.\"

It has been changed to "depolarize the membrane".

> 10\) I\'m not 100% sure, but I didn\'t think worm TMC-1 and TMC-2 are specifically homologous to (respectively) TMC1 and TMC2.

We have deleted the sentence "It also indicates different TMC functions crossing species; as it has been proposed that both TMC-1 and TMC-2 confer the leak conductance in worms" in the Discussion section.

> 11\) Discussion section. I don\'t understand this sentence: \"However, it is still not yet explained that only a quarter proportion of TMC1 proteins are localized at the MET site, whereby counting around 2 MET complexes exist...\"

It has been changed to "However, not all TMC1 proteins are localized at the MET site, where only up to 2 MET channel complexes exist" in the Discussion section.

> 12\) The interpretation of the IV curves needs to be clarified. I would assume that the IV curves represent complex currents, not just leak and MET but other voltage gated channels as well. Would further assume the outward currents are not affected by NMDG but rather by the internal ions. So how these plots are interpreted is important and might be different depending on the voltage range that is investigated.

Yes, I~m~ represents complex currents that include leak current, resting MET current, and other channels. Because NMDG was applied only extracellularly, the inward currents but not outward currents were affected by NMDG. Then we only calculated the inward background current (I~m~-I~NMDG~) from recordings similar to Figure 1F and I~BG~ was used in Figure 1 and Figure 2. However, as you mentioned that the I~background~ was still complex. According to the investigation requirement, we then used I~Leak~ to describe the leak current that may mostly represent the contribution by TMC1 (Figure 3, Figure 4, Figure 5, Figure 6, Figure 7 and Figure 8). The aim of I-V experiments was to show the voltage dependence of these inward background currents. We have updated sentence in subsection "TMC1 but not TMC2 mediates a background current in hair cells" to "Furthermore, the voltage dependence of I~m~ and I~NMDG~ was analyzed by applying a series of voltage-pulse stimuli to OHCs (Figure 1F-I). The I~m~-V curves obtained from these measurements verified a reduced I~m~ (Figure 1G) and a more negative reversal potential (Figure 1H) in Tmc1-knockout OHCs. After subtraction (only inward I~BG~ was calculated because NMDG was applied extracellularly), it was clear that the I~BG~ altered almost linearly with holding potentials and was dramatically reduced in Tmc1-knockout OHCs (Figure 1I)."

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

> The manuscript has been improved but there are some minor revisions that are necessary for clarity, as outlined below:
>
> Title:
>
> TMC1 Is an Essential Component 1 of a Leak Channel Underlying Tonotopy and Excitability of Auditory Hair Cells in Mice
>
> Change \"underlying\" to \"that modulates\".

In the revised manuscript, "underlying" has been changed to "that modulates" in the title.

> Abstract:
>
> Change to \"The leak conductance is graded in frequency-dependent manner along the length of the cochlea...\".
>
> our results showed -- change to \"show\".

In the revised version, "The leak conductance is graded in frequency-dependent manner..." has been changed to "The leak conductance is graded in frequency-dependent manner along the length of the cochlea..." on page 2, line 30 and "showed" has been changed to "show" in the Abstract.

> Introduction:
>
> \"it is a pore-forming subunit\" -- define what \"it\" is.

In the revised version, "it" has been changed to "TMC1" in the Introduction.

> Results:
>
> It is noteworthy to point out that, I~BG~ was used as the title of vertical axis to show the dosage effect (Figure 5), but it represented the leak component when the concentration of blockers was high enough.
>
> Revise -- it is not clear which leak component you are referring to:

In the revised version, this sentence has been updated to "It is noteworthy to point out that the I~BG~ included the I~Resting-MET~ and the I~Leak~ when the concentration of the blockers was low, but the I~BG~ was mainly composed of the I~Leak~ when the concentration of blockers was high enough (Figure 5)." in subsection "Pharmacological blockade of the TMC1-mediated leak conductance".

> A significant leak conductance would be expected in order to depolarize the membrane and affect cell excitability,
>
> Revise -- \"would be expected to depolarize...\",

In the revised version, "would be expected to in order to depolarize..." has been updated to "would be expected to depolarize..." in subsection "The leak current modulates action potential firing in IHCs".

[^1]: These authors contributed equally to this work.
